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Cobalamin, also known as vitamin B12, is used as a coenzyme for key enzymes 
involved in the S-adenosyl methionine (SAM) cycle and branched-chain amino acid 
(BCAA) metabolism, which lead to many downstream targets. Thus, B12 is required 
for many physiological functions including DNA synthesis, cell division, erythrocyte 
production, and myelin sheath maintenance. Biologically active B12 is produced by a 
select group of bacteria, mainly by fermentation in the gastrointestinal tract of animals, 
and archaea. Humans must acquire B12 from animal products, and B12 deficiency is 
associated with pernicious anaemia and neural deterioration. However, deficiency is 
only acquired after several years, therefore studying B12 action and transport in an 
animal model where B12-deficiency can be induced in a few weeks is both cost- and 
time-efficient. This project investigates the role and transport of B12 in the nematode 
C. elegans, with the outlook that it could be used as a whole animal model to fully 
understand its action.  
B12-deficiency was induced in C. elegans by growing them on media lacking this 
vitamin, and found that it caused delayed life cycle, reduced lifespan, and a reduction 
in progeny. After noticing that B12 deficiency had a negative impact on lifespan, and 
knowing that B12 is important for neuronal function in humans, the effects of B12-
deficency on C. elegans neuronal branching with age, which is related to 
neurodegeneration, were examined. We found that B12-deficient worms had earlier-
onset and increased neurite branching indicating the interesting possibility that this 
aspect of B12 function could be modelled in worms.  
In conclusion, we found that B12-deficiency had a detrimental effect on C. elegans 
health in general, and that this nematode is a good model for studying the action of 
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ABC transporter ATP-binding cassette transporter 
ACDH-1 Acyl-CoA dehydrogenase (C. elegans protein) 
AdoCbl Adenosylcobalamin 
ALML Anterior lateral MT cell (left) 
ALMR Anterior lateral MT cell (right) 
ATP Adenosine triphosphate 
AVM Anterior ventral MT cell 
B12 Vitamin B12 
B12+ M9 solid C. elegans media supplemented with 100 µg/L 
of cyanocobalamin 
B12- Non-supplemented M9 solid C. elegans media 
BCAA Branched-chain amino acid 
BoB12 BODIPY-B12 
BODIPY Boron-dipyrromethene - BODIPY® TR-X NHS Ester 
(Succinimidyl Ester) 
bp Base pairs 
C. elegans Caenorhabditis elegans 
Cbl Cobalamin 
CDI 1,1'-Carbonyldiimidazole 
CGC Caenorhabditis Genetics Center 
CN Cyanide 
CNCbl Cyanocobalamin 
-CoA Coenzyme A 
CZ10175 zdIs5[mec-4p::GFP + lin-15(+)] I. C. elegans strain 
DMBI 5,6-dimethylbenzimidazole 
dH2O Distilled water 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
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dNTP Deoxyribonucleotide triphosphate 
E. coli Escherichia coli 
ESI-MS Electrospray ionisation mass spectrometer 
EtOH Ethanol 
FuDR Fluorodeoxyuridine 
GFP Green fluorescent protein 
HC Haptocorrin 
Hcy Homocysteine 
HPLC High performance liquid chromatography 
HPLC-MS High performance liquid chromatography - Mass 
spectrometry 
IF Intrinsic factor 
LB Luria-Bertani media 
MAP2 Microtubule-associated protein 2 
mCeHR Modified C. elegans Habituation and Reproduction media 
MCM Methylmalonyl-CoA mutase (Human) 
MeCbl Methylcobalamin 
MMCM-1 Methylmalonyl-CoA mutase (homolog-1) (C. elegans) 
MQ H2O Milli-Q water (ultrapure water) 
MRP-5 Multidrug resistance-associated protein 5 
MS Methionine synthase 
MT cell Touch receptor neurons (containing large-diameter, 15-
protofilament microtubules) 
N, N-DIPEA/DIPEA N,N-Diisopropylethylamine 
N2 N2 Bristol C. elegans strain (wild-type) 
NADPH Nicotinamide adenine dinucleotide phosphate (reduced 
form) 
NGM Nematode growth media 
NHS ester N-hydroxysuccinimide ester 
NR Nerve ring 
OP50 B-type E. coli strain OP50 - uracil auxotroph  
PCR Polymerase chain reaction 
PLML Posterior lateral MT cell (left) 
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PLMR Posterior lateral MT cell (right) 
Prop-CoA Propionyl-CoA 
PTL-1 Protein with tau-like repeats-1 
PVM Posterior ventral MT cell 
RFP Red fluorescent protein 
ROS Reactive oxygen species 
SAM S-Adenosyl methionine 
Succ-CoA Succinyl-CoA 
TC Transcobalamin 
TFA Trifluoroacetic acid 
UV Ultraviolet 







This project examines the function and localisation of vitamin B12 in C. elegans. This 
will allow us to understand more about the role of this vitamin in this model organism, 
which should later inform studies in higher organisms. 
Vｷデ;ﾏｷﾐ Bヱヲ 
Vitamin B12 is usually used as an umbrella term for all forms of cobalamin that are 
bioactive in humans, with particular emphasis on the most commonly available 
commercial derivative, cyanocobalamin. Cobalamin is a water-soluble molecule 
comprised of a tetrapyrrole corrin ring, which is formed by a cobalt ion flanked by 
four nitrogen atoms, as well as a variable upper く-axial ligand, and 5,6-
dimethylbenzimidazole (DMBI) base as its lower g-axial ligand (Fig. 1) (Gherasim et 
al., 2013; Kumar and Kozlowski, 2017). There are multiple cobalamin analogues 
which can be produced by changing the upper く-ligand of the compound. In the case 
of the majority of industrially synthesised vitamin B12 the upper ligand is formed by 
cyanide, which forms cyanocobalamin. Cyanocobalamin is a stable, cost effective, and 
bioactive form of B12, as well as being easy to crystallise, so it is the most common 
form available in supplements (Obeid et al., 2015; Watanabe et al., 2013). B12 is 
absorbed in the small intestine and converted to two active forms of vitamin B12 in the 
body: methylcobalamin (MeCbl), which has a methyl- group, and adenosylcobalamin 
(AdoCbl), which has a 5’-deoxyadenosyl (Ado) group, as their く-ligands. 
Some bacteria and most cyanobacteria produce a form of B12 known as 
pseudocobalamin, which humans cannot convert to the active forms AdoCbl and 
MeCbl. In pseudocobalamin, the base of the g-axial position in the lower nucleotide 
loop is substituted with adenine (Fig. 1). Spirulina, which is often recommended as a 
vegan source of vitamin B12, has been shown to mainly produce this non-bioactive 
cobalamin analogue (Watanabe et al., 2007; Watanabe et al., 1999). This is a problem 
for vegetarians, and vegans, in particular, as if they do not take B12 supplements they 




                                       
 
B12 is synthesised only by a select group of bacteria and archaea, either via an aerobic 
or anaerobic pathway (Fang et al., 2017). B12 biosynthesis is mediated by a select but 
broad group of prokaryotes, but in all cases, cobalt is essential for the synthesis of the 
molecule. Industrial production of B12 is usually carried out by P. denitrificans, P. 
shermanii, and S. meliloti, although industrial production of B12 using recombinant E. 
coli is also being studied (Martens et al., 2002). There are many species of E. coli, one 
of which (called OP50) is used as a food source for the C. elegans in this project. OP50 
does not produce vitamin B12, which allows us to accurately control the amount of this 
compound administered to the nematodes via their growth media.  
 
 
Figure 1. Structure of vitamin B12 (cyanocobalamin). Corrinoid tetrapyrrole ring 
with 5,6-dimethylbenzimidazole (DMBI) attached via the lower loop (box on the 
left). The upper く ligand in this case is cyanide (CN). The base in the box on the 
right is adenine. The unbound single bond is where the base binds to the lower g-







Vｷデ;ﾏｷﾐ Bヱヲ SWaｷIｷWﾐI┞ ｷﾐ ｴ┌ﾏ;ﾐゲ 
In humans, the uptake of vitamin B12 is mediated by haptocorrin (HC) and intrinsic 
factor (IF), each of which carry a single B12 molecule. First, B12 is released from the 
food during chewing and in the stomach due to gastric acid and pepsin. It then binds 
to HC, a glycoprotein secreted in saliva and the parietal cells of the stomach, which 
binds all cobalamin analogues indiscriminately. Once in the duodenum (beginning of 
the small intestine), the higher pH causes HC to be degraded by pancreatic proteases, 
allowing IF to bind the B12. In the ileum (distal small intestine), the IF-B12 complex 
enters the mucosal cells by specific receptor-mediated endocytosis, which degrades 
the IF, subsequently freeing the B12. The free B12 enters the systemic circulation, where 
it binds to transcobalamin (TC) (Kozyraki et al., 2013). The B12-TC complex is known 
as holotranscobalamin, and is the bioactive form of B12 that is delivered to the cells. 
The fact that humans need a very small amount of vitamin B12, and that B12 is also 
stored in the liver, means that in healthy humans with no uptake disorders, the onset 
of B12 deficiency can take months to years. 
Humans also have B12-producing bacteria as part of their gut microflora, however they 
are found in the large intestine. As this vitamin is absorbed in the small intestine, 
humans cannot absorb the B12 produced in our own guts and must obtain it from our 
diet. The daily recommended amount of vitamin B12 for adults is determined at around 
1.5 µg in the UK (Wiseman, 1992), and 2.4 µg in the USA. Foods containing utilisable 
B12 analogues include meat, fish and dairy products, where it is synthesised by their 
gut microbiota and stored in the muscles and liver, or secreted in milk. 
Due to the fact that crop-based foods do not contain cobalamin, strict vegetarians and 
vegans are more prone to vitamin B12 deficiency (Antony, 2003; Pawlak, 2015; De 
Rosa et al., 2012). Vitamin B12 deficiency is rare in developed countries, however, 
people in developing countries that have a predominantly plant-based diet (e.g. India) 
are at higher risk, with rates rising to up to 80% (Naik et. al., 2018). In addition, the 
rate of B12-deficiency among the elderly rises up to 20%, as they are predisposed due 
to reduction in the efficiency of absorbance due to diseases such as atrophic gastritis, 
which increases with age, and reduces the amount of gastric acid and IF produced 
(Andres, 2004). In the elderly, vitamin B12 deficiency is strongly associated with 
increased oxidative stress and cognitive decline (Solomon, 2015). 
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Vitamin B12 deficiency can also be caused by malabsorption disorders or infections. 
Gastric intrinsic factor (IF) is necessary for B12 uptake and vitamin B12 deficiency 
caused by lack of this transport factor causes pernicious anaemia. This type of anaemia 
is caused by a shortage of red blood cells, due to inhibition of DNA synthesis during 
the production and maturation of red blood cells in the bone marrow. Vegetarians and 
vegans that ingest high quantities of folate (vitamin B9) from dark green leafy 
vegetables are protected from this disease, however this masking effect of folate in 
pernicious anaemia may prevent the diagnosis of B12 deficiency, which leads to other 
complications (Herrmann and Obeid, 2011). B12-deficiency by infection can be caused 
by Helicobacter pylori, which causes gastric atrophy and lack of gastric acid, leading 
to impaired absorption of B12. Infection by parasitic nematodes, such as fish tapeworm 
(Diphyllobothrium latum), can also cause deficiency due to competition for vitamin 
B12 in the intestine (Allen, 2008; Bonsdorff and Gordin, 2009). 
Vitamin B12 is needed for DNA synthesis (which requires tetrahydrofolate), cell 
maintenance and division, neurotransmitter synthesis, and erythrocyte production 
(Fenech, 2001; Dror, 2008; Battaglia-Hsu, 2009; Greer, 2014). It is also involved in 
normal neural function, as methionine is necessary in myelin repair and maintenance 
in the central and peripheral nervous system. B12 acts as a cofactor for methionine 
synthase, which recycles methionine from homocysteine (Miller, 2005; Scalabrino, 
Veber and Tredici, 2014). B12 deficiency causes the accumulation of homocysteine 
and lower amounts or methionine, which subsequently causes a variety of symptoms 
downstream of the SAM cycle.  
In adults, initial B12 deficiency symptoms include fatigue, reduced sensitivity to touch, 
tremors, and blurred vision. As B12 becomes depleted from the liver and the deficiency 
increases, symptoms become more severe, and can include memory loss, mood swings, 
depression, seizures, and permanent neurological disorders such as multiple sclerosis 
and dementia (Savage, 1995; Kocer, 2009; Chien Tu et al., 2017; Irevall, 2017). In 
infants, it can cause hypotonia (low muscle tone) and neurodevelopmental retardation, 
however, if diagnosed early on, the symptoms can be reversed with B12 
supplementation (Taskesen et al., 2012). 
The onset of severe vitamin B12 deficiency can take years, which is why it is usually 
diagnosed in time to be reversed with B12 administration. When B12 deficiency is in its 
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advanced stages, or if the patient has a disease which impairs the absorption of this 
vitamin, B12 is administered via intramuscular injections, however oral B12 
supplements are enough to replenish B12 to normal levels in the beginning (Morita et 
al., 2003; Shyambabu et al., 2008). Vitamin B12 deficiency is usually first tested by 
measuring total serum cobalamin because of its low cost compared to other tests. 
According to this test, B12-deficiency is defined as having less than 200 pg/ml of B12 
in the serum (Green, 1995; Herrmann et al., 2000). B12 insufficiency diagnosis is 
important as it can be simply reversed by the administration of oral supplements, which 
is easier and cheaper for the patient than injections, and it avoids reaching the point of 
severe neurological deficiency symptoms. 
Only two enzymes are B12-dependent in mammalian cells: L-methylmalonyl-CoA 
mutase (MCM) and methionine synthase (MS). AdoCbl is a coenzyme of 
methylmalonyl-CoA mutase (MCM), which is involved in the breakdown of branched-
chain amino acids (BCAAs), cholesterol, and fatty acids in the mitochondria by 
catalysing the conversion of methylmalonyl-CoA to succinyl-CoA. MeCbl is a 
cofactor of methionine synthase, which catalyses the conversion of homocysteine to 
methionine in the cytoplasm as part of the S-Adenosyl methionine (SAM) cycle, which 
recycles methionine. B12-deficiency causes the accumulation of homocysteine (Hcy), 
as well as lower amounts of methionine in the SAM cycle. The accumulation of Hcy 
causes hyperhomocysteinemia, leading to the activation of NADPH oxidase, which 
generates reactive oxygen species (ROS) and, consequently, superoxide anions, 
hydrogen peroxide, and hydroxyl radicals (Labuschagne and Brenkman, 2013). This 
can lead to vascular dysfunction, neurodegenerative diseases (e.g. Alzheimer’s, 
seizures), neural tube defects in infants (Obeid and Herrmann, 2006; Herrmann and 
Obeid, 2011; Edirimanne et al., 2007). While only two enzymes are B12-dependant in 
humans, B12 deficiency causes a wide variety of downstream detrimental effects. Thus, 
it is important to study B12 deficiency in a model that is effective and time-efficient, 





Cく WﾉWｪ;ﾐゲ ;ゲ ; ﾏﾗSWﾉ ﾗヴｪ;ﾐｷゲﾏ  
C. elegans has only recently been studied and as a model for B12-deficiency. These 
nematodes are hermaphroditic and have short life cycles, which allows for 
maintenance of strains without genomic variability. The short life cycle of these 
nematodes also allows rapid depletion of B12, which allows studies which would not 
be possible to carry out with higher organisms (as it can take several years for a 
mammal to acquire vitamin B12 deficiency). In addition, their short lifespans also allow 
ageing studies which may take months or years in other model organisms (Lian Chew 
et al., 2013). Their growth media and environment can be specifically modified and 
controlled, enabling control of the exact amount of vitamin B12 administered. The 
transparency of these nematodes enables us to carry out B12 localisation studies in vivo 
by using fluorescent cobalamin analogues. Whilst C. elegans cannot be used as a 
model for human B12 intestinal transport, as they lack the equivalent human transport 
proteins, they can be used as a model to study the absorbance of B12 in parasitic 
nematodes. This could elucidate a drug target for the B12-deficiency causing intestinal 
parasites. On the other hand, C. elegans can be used as a model for the neural effects 
of B12-deficiency in humans. Their neuronal network is composed of 302 neurons and 
has been extensively studied and mapped, and markers for neural ageing have been 
established, such as neurite branching (White et al., 1986). In addition, they have been 
used as models for human Alzheimer’s, Parkinson’s, and other tauopathies and 
neurodegenerative diseases (Li and Le, 2013; Alexander, Marfil and Li, 2014; Wang 
et al., 2018). They are comparable to humans as they also require vitamin B12 for their 
growth and development, and the enzymes requiring B12 as well as the metabolic 
pathways are conserved.  
The life cycle of C. elegans (Fig. 2), from egg to adult worm, lasts approx. 3 days. N2 
Bristol strain worms were used in this study as wild type (WT), which have an 
approximate lifespan of 12 to 20 days (Gems and Riddle, 2000). C. elegans were 
maintained on nematode growth medium (NGM) with the uracil auxotroph B strain 





Vｷデ;ﾏｷﾐ Bヱヲ ｷﾐ Cく WﾉWｪ;ﾐゲ 
C. elegans require vitamin B12 as AdoCbl and MeCbl, and have conserved metabolic 
pathways and enzymes with humans. However, C. elegans can rewire their metabolic 
network to a secondary pathway that does not require vitamin B12 in order to survive 
when vitamin B12 is not readily available (Watson et al., 2016). This may have evolved 
as a survival mechanism, as in the wild they may encounter a variety of environments, 
some with B12-producing bacteria (e.g. soil containing faecal matter), and others with 
low amounts of B12-synthesising bacteria. The B12-dependent pathway is known as the 
carboxylation pathway and is conserved in both humans and nematodes, however C. 
elegans can convert to the secondary B12-independent pathway, known as the く-
oxidation-like pathway, in environmental conditions lacking B12 (Fig. 3). The 
breakdown of odd-chain fatty acids and branched-chain amino acids (BCAA) 
Figure 2. C. elegans life cycle at 25°C. A. Diagram of each stage of the life cycle 
at 25°C, including average time between stages (Modified from Altun and Hall, 




produces propionate is interconverted with propionyl-CoA, a toxic intermediate if it 
accumulates in the cell. Vitamin B12 acts as a cofactor of methylmalonyl-CoA mutase 
(mmcm-1, the C. elegans ortholog of human MCM), which catalyses the conversion 
of L-methylmalonyl-CoA ((L)-MM-CoA) to succinyl-CoA (Succ-CoA) in the 
carboxylation pathway. B12 deficiency and propionic acidemia prevent the catabolism 
of propionate, which causes toxic intracellular build-up (La Marca et al., 2007).  
 
Figure 3. Propionate breakdown pathways. Vitamin B12-dependent species use 
a carboxylation pathway to catabolise propionate. B12-independent species use 
either the methylcitrate pathway or the く-oxidation-like pathway. C. elegans uses 
the carboxylation pathway in the presence of B12 and the く-oxidation-like pathway 
in B12-deficient environments. MMCM-1: methylmalonyl-CoA mutase-1 (C. 
elegans ortholog of MCM); ACDH-1: acyl-CoA dehydrogenase; 3-HP: 3-





Whilst C. elegans can use either pathway depending on vitamin B12-availability, other 
organisms are thought to have a preference of one over the other, or just one pathway 
available. B12-dependent species include humans and most animals, while B12-
independent species that use the methylcitrate pathway include S. cerevisiae and ones 
that use the く-oxidation-like pathway include plants and C. albicans (Otzen et al., 
2014). In humans, a marker of propionic acidemia is elevated levels of 3-
hyroxypropionate (3-HP), which suggests that the secondary B12-independent く-
oxidation-like pathway of propionyl-CoA (prop-CoA) catabolism may be conserved 
in some manner (Watson et al., 2016).  
Vitamin B12 deficiency in C. elegans has been shown to cause elongated life cycle, 
reduced lifespan, and reduced fertility (Bito et al., 2013; Bito and Watanabe, 2016). 
Comamonas aquatica, which naturally produces vitamin B12, has been shown to 
increase developmental rate when used as a food source for the worms (Watson et al., 
2014; MacNeil et al., 2013). B12 deficiency has also been shown to cause oxidative 
stress, which impacts the nervous system by causing a memory retention decreased of 
42% (Bito et al., 2017). C. elegans can also acquire B12 deficiency via the introduction 
of the cobalamin analogue cyanocobalamin dodecylamine, which has a higher affinity 
for the B12-dependent enzymes than AdoCbl and MeCbl (Bito et al., 2014). 
A marker for ageing in C. elegans is neuronal branching, which has been shown to be 
influenced by oxidative stress, the Jun kinase pathway, and the insulin signalling 
pathway (Tank, Rodgers and Kenyon, 2011; Toth et al., 2012). This phenotype of 
neurite branching and blebbing (beading of axons) with age is typically studied in the 
mechanosensory “touch receptor” neurons, visualised by labelling with a mec-
4p::GFP reporter, which fluorescently tags the MEC-4 ion channel (required for gentle 
touch sensation) (Lian Chew et al., 2013; Suzuki et al., 2003). These morphological 
defects are accompanied by a decline in response to touch, indicating functional 
deterioration (Pan et al., 2011). Neurite branching has also been observed in humans 
with Alzheimer’s disease (Masliah et al., 1993; Hashimoto and Masliah, 2003; Gordon, 
Hegedus and Tam, 2004). 
The uptake mechanism of B12 and the effects of vitamin B12 deficiency are still not 
completely elucidated, particularly in the model organism C. elegans. This project 
aims to shed light on the phenotypic effects of vitamin B12 deficiency, as well as the 
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uptake and localisation of B12 in these worms. As part of an ageing laboratory, we will 
be particularly focusing on the effect of this deficiency on ageing phenotypes, such as 
development, lifespan, and neurodegeneration. In addition, we will study B12 uptake 
in vivo by using fluorescent cobalamin analogues. This investigation will expand our 
knowledge of the phenotypic effects of this deficiency and establish the use of C. 
elegans as a suitable model for B12 deficiency regarding development, fertility, and 
neurodegeneration. In addition, the study of fluorescent B12 localisation in these 
nematodes may determine a method for investigating molecular trafficking in vivo, as 




Materials and Methods 
RWゲﾗ┌ヴIWゲ 
Strains 
E. coli OP50 uracil auxotroph: gift from J. Tullet. E. coli: OP50 (pET-BAD-btuBF): 
gift from A. Lawrence. Bristol N2 C. elegans strain: gift from J. Tullet at the University 
of Kent. VC1011 acdh-1(ok1489) I. C. elegans strain: purchased from CGC, 
University of Minnesota, MN. CZ10175 (zdIs5[mec-4p::GFP + lin-15(+)]I.) C. 
elegans strain: gift from B. Schafer's lab at the LMB Cambridge.  
Reagents 
Reagents were purchased from Sigma Aldrich (now Merck), or Thermo Fischer 
Scientific Inc., when specified. BODIPY® TR-X NHS Ester (Succinimidyl Ester) was 




10x M9 solution 
60 g Na2HPO4, 30 g KH2PO4, 10 g NH4Cl, 5 g NaCl, make up to 1 L with MQ water 
and autoclave. 
M9 buffer 
6 g Na2HPO4, 3 g KH2PO4, 5 g NaCl, make up to 1 L with MQ water and autoclave. 
After solution cools down, add 1 ml autoclaved/sterile 1 M MgSO4. 
BODIPY® TR-X ribose-linked cyanocobalamin (BoB12) 
BoB12 was synthesised as described previously (Lawrence et al., 2018). 1,1’-
carbonyldiimidazole (CDI) was used to activate the 5’ ribose hydroxyl group of 
cyanocobalamin, and was then coupled with 1,2-Diaminoethane as described 
previously, forming a primary amine (McEwan et al., 1999; Lee and Grissom 2009). 
BODIPY® TR-X dissolved in anhydrous DMSO was added in excess (1.5x), along 
with N, N-DIPEA as an organic base. The reaction was incubated on a shaker in the 
dark for 24 hours at room temperature. The product was precipitated with a solution 
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of 50% acetone and 50% ethyl acetate, centrifuged, and dried down using pressurised 
air. The BoB12 was then resuspended in 50% methanol and purified and confirmed by 
HPLC-MS (Agilent 1100 series HPLC coupled to a micrOTOF-Q (Bruker) mass 
spectrometer).  
The initial semi-preparative HPLC separated large amounts of impurities from our 
sample by identifying the elutions using the UV spectra. 200 µl of our sample was 
injected at a time into a ‘CS SIL C18’ column (250 mm x 10 mm, 5 たm; Charlton 
Scientific) column on an Agilent 1100 series HPLC. The sample was run at a 4.5 
ml/min flow rate using 0.1 % (v/v) TFA (solvent A) and 100 % acetonitrile (solvent 
B) running from 5% to 95% in 50 min (and back again to restore the column), with the 
column kept at 25 °C. 
For the preparative HPLC-MS, the previous HPLC purified sample was mixed with 
one-part ultrapure water. 20 µl of sample was injected at a time, and the protocol was 
run at a 0.2 ml/min flow rate using 0.1 % (v/v) TFA (solvent A) and 100 % acetonitrile 
(solvent B), with the Ace 5 AQ column (2.1 x 150 mm, 5 たm, 100 Å, from Advanced 
Chromatography Technologies) column kept at 25 °C. The product was confirmed 
using positive mode electrospray ionisation on an electrospray ionisation mass 
spectrometer (ESI-MS) (Bruker micrOTOF II-MS) (Fig. S5 of supplemental data). 
 
B;IデWヴｷ;ﾉ ﾏWデｴﾗSゲ 
OP50 uracil auxotroph E. coli was used as a food source for C. elegans. The E. coli 
were grown in LB media for the NGM plates, and in minimal M9 media for the M9 
plates, as this has been shown to reduce the amount of vitamin B12 contained in them 
(0.2 たg/g wet weight in M9 media vs. 11.1 たg/g wet weight in LB media) (Bito et al., 
2013). The E. coli was grown in a shaker overnight at 37°C (for all conditions), then 
used to seed the plates, which were left overnight to dry before using. 
LB media 
2 g LB powder, 80 ml dH2O, dissolve and autoclave. 
M9 media 
Autoclave 900 mL MQ H2O and cool. Add 100 mL 10x Salt Solution. Add (sterile): 1 
mL 1M MgSO4 solution, 0.5 mL 1M CaCl2 solution, 1 mL 4 g/L thiamine 
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hydrochloride solution, 10 mL 20% w/v glucose solution, 10 ml 2 g/L uracil solution, 
mix and store. 
Cobalamin analogue uptake in E. coli 
Cobalamin analogue brood size rescue assay: 
Inoculate 5 ml of media (LB or M9) with OP50 E. coli containing the pET-TBAD 
btuBF plasmid (Fig. S6 of supplemental data). Incubate overnight at 37°C and then 
take 200 µl of the starter culture and inoculate 5 ml of media (again either LB or M9). 
Grow for 4 hours at 37°C, then add 10 µl of 5% arabinose and the respective cobalamin 
analogues to a concentration of 1 µM. Grow overnight at 28°C, then seed the plates 
(NGM plates for LB cultures, M9 plates for M9 cultures). The conditions we used 
were: LB, M9, M9 with cyanocobalamin, M9 with pseudocobalamin, and M9 with 
BoB12. 
BoB12 localisation assay: 
BoB12 was introduced into the E. coli as described previously. However, before 
seeding the plates, the culture was spun down and resuspended in M9 media three 
times to get rid of extracellular BoB12 that had not been internalised. To verify that the 
BoB12 had been taken up, the E. coli was imaged using an Olympus IX-81 inverted 
fluorescence microscope at 100x magnification using an RFP 580 filter (BODIPY® 
TR-X fluorophore has an excitation of 588 nm and an emission of 620 nm). A drop of 
the washed OP50 pET-TBAD btuBF E. coli incubated with BoB12 was placed on a 
glass slide, a cover slip was placed on top and sealed with clear nail polish to prevent 
drying out, and imaged. Brightfield images were then overlaid with the fluorescence 
images to confirm colocalisation of BoB12 and E. coli, verifying the uptake of BoB12. 
Cく WﾉWｪ;ﾐゲ ﾏWデｴﾗSゲ 
C. elegans strains were maintained either on nematode growth media (NGM) seeded 
with E. coli OP50 LB culture, on M9 agar seeded with E. coli OP50 M9-media culture, 
or on B12-supplemented M9 agar seeded with E. coli OP50 M9-media culture. 
Nematode Growth Media (NGM) 
3 g NaCl, 17 g Agar, 2.5 g Bactopeptone, 1 L H2O, autoclave and cool to 55°C. Add 
(sterile): 25 mL 1M KH2PO4 (pH 6), 1 mL 1M MgSO4, 1 mL 1M CaCl2, 1 mL 5 mg/ml 




17 g agar, add 900 mL dH2O, autoclave and cool to 55°C. Add 100 mL 10x Salt 
Solution. Add (sterile): 1 mL 1M MgSO4 solution, 0.5 mL 1M CaCl2 solution, 1 ml 4 
g/L Thiamine hydrochloride solution, 10 ml 20% w/v Glucose, 10 ml 2 g/L Uracil, 1 
ml 5 g/L Cholesterol in EtOH (for B12-supplemented plates, add 100 µL of 1 g/L 
cyanocobalamin). Pour plates, let set, and store. 
Axenic liquid media (mCeHR-2 media)  
The modified C. elegans habituation and reproduction media (mCeHR-2) was 
produced as described previously (Samuel et al., 2014), with the protocol being 
provided by I. Hamza at the University of Maryland. Using sterile technique and a 1L 
(0.2 µm) vacuum filter unit, filter the following volumes of stock solutions and water 
in the order described. 10 ml choline (100x), 10 ml vitamin mix (100x), 10 ml i-Inositol 
(100x), 20 ml nucleic acid mix (50x), 280 ml dH2O. Vacuum filter. Add 20 ml salt 
solution (50x), 20 ml lactalbumin (50x), 20 ml essential amino acid mix (50x), 10 ml 
non-essential amino acid mix (100x), 20 ml KH2PO4 (50x), 50 ml d-glucose (20x), 10 
ml HEPES (100x), 319 ml dH2O, and vacuum filter again. Remove filter unit and add 
(sterile) 1 ml 5 mg/ml cholesterol, and 200 ml high temperature ultra-pasteurized skim 
milk. 
Single worm lysis and PCR 
Single worm lysis: 10 µl of Single Worm Lysis Buffer (50 mM KCl, 10 mM Tris-HCL 
[pH 8.3], 2.5 mM MgCl2, 0.45% NP-40, 0.45% Tween 20, 0.01% Gelatin) and 1 
mg/ml of Proteinase K (For 1 ml: 20 mg Proteinase K, 949 µl dH2O, 50 µl 1 M Tris 
[pH 8], 1 µl 1 M CaCl2) were pipetted into the cap of a 0.2 ml PCR tube. A single 
worm was transferred to the buffer and the tube was spun in a microcentrifuge (1 G 
for 1 min). The worm(s) were frozen at -80°C for 2 hours, then incubated at 65°C for 
1 hour, and then at 95°C for 30 min. PCR: Each sample (single worm lysed in 5 µl of 
buffer), was divided into two tubes (2.5 µl each), and one was stored at -20°C. To the 
other tube (containing 2.5 µl of sample DNA), we added 11 µl ultrapure water, 2.5 µl 
10x Taq buffer, 2.5 µl 25 mM MgCl2, 2 µl 2.5 mM dNTPs mix, 2 µl 10 µM 5’ (forward) 




Making B12-deficient C. elegans 
To make the C. elegans B12-deficient, they were grown on 1.7% (w/w) M9 agar plates 
containing OP50 E. coli grown in M9 media as a food source, and were maintained at 
20°C. First, the worms were grown on the M9 plates supplemented with 100 µg/L of 
cyanocobalamin using the B12-deficient E. coli (grown in M9 media) as a food source. 
An individual egg was transferred on to each B12-supplemented M9 plate and allowed 
to develop into an egg-laying adult. Another egg was then transferred to a new plate. 
This was repeated at least 10 times before experiments were carried out, and these 
worms were then used as the “B12+” condition. To make the worms B12-deficient, eggs 
from the B12-supplemented M9 plates were taken and each placed on to an individual 
non-supplemented M9 plate seeded with B12-deficient E. coli. They were maintained 
at 20°C and allowed to lay eggs. As with the previous condition, each egg was placed 
on to a new M9 plate and allowed to grow into an egg-laying adult. This process was 
repeated for at least five generations before the worms were used in experiments, as 




Several adult worms from each condition were transferred on to fresh plates of the 
same medium and left to lay eggs for 5 hours. The adult worms were removed and the 
plates were incubated at 20°C. 24, 48, 60, and 84 hours later, the worms were imaged 
on the Leica DMR microscope at either 10x (for L3, L4, and adult worms) or 20x (for 
L1 and L2 stage worms) magnification. The worms were then measured from the 
images using the Leica Application Suite X (LAS X) software by drawing a continuous 
line from the mouth to the end of the tail through the midline of the worm, which the 
software used to convert pixels to µm. 
Lifespan assay 
The lifespan assay was carried out by placing L4-stage worms (100 worms per 
condition) from each condition onto fresh plates containing the same culture media as 
well as FuDR to prevent egg-hatching, and incubated at 20°C. Worms were scored as 
dead when they no longer responded to prodding with a pick. Worms dead from 
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unnatural causes (internal hatching, gut explosion, etc.) and escaped worms were 
censored. 
Brood size assay 
Fecundity was measured via brood size assays, which count the number of eggs laid 
by each worm (that hatch). Individual worms at stage L4 grown on NGM, B12-
supplemented M9 media, or B12-deficient M9 media, were transferred on to fresh 
plates containing their same respective media. After incubation at 20°C for 24 hours, 
each adult worm was transferred to a new empty plate. The plates they were moved 
from were incubated at 20°C for a further 24-36 h and the hatched progeny was 
counted. 
Neurite branching assay 
Young adult worms were placed on NGM, B12-supplemented M9, and M9 plates 
during 5 hours for a timed egg lay, after which they were picked off. The offspring 
were allowed to hatch and develop at 20°C for three days, after which they were placed 
on corresponding plates containing FuDR. On adult days 1, 8 and 15 they were imaged 
on the Leica DMR microscope at 10x and 20x magnification using a GFP filter. 2% 
w/v agarose pads with 5 µl of 0.06% w/v tetramisole hydrochloride were used to 
immobilise the nematodes. Worms were scored as either positive or negative for 
neurite branching. 
BoB12 localisation 
BoB12 was synthesised and introduced into E. coli as described previously (Lawrence 
et al., 2018) and localisation was studied in two different medias: liquid and solid. 
Liquid media: Eggs from a bleach drop were placed in modified C. elegans habituation 
and reproduction media (mCeHR) supplemented with 3.3 µM of BoB12 and incubated 
in a shaker at 20°C until adult stage. Worms were then washed three times in M9 to 
remove BoB12 that had not been taken up and imaged. Solid media: Adult worms were 
placed on B12-deficient M9 media seeded with the OP50 BtuBF E. coli containing 1 
µM BoB12 and allowed to lay eggs. The adults were removed and the eggs were 
incubated at 20°C for three days. The adult-stage worms were then imaged on 2% 
agarose pads with 0.06% tetramisole hydrochloride on an Olympus IX-81 inverted 
fluorescence microscope at 60x magnification using an RFP 580 filter. Brightfield 
25 
 
images were then overlaid with the fluorescence images to confirm the localisation of 
the BoB12 to the coelomocytes. 
Cobalamin analogue brood size rescue assay 
Brood size was carried as described previously, but B12-deficient L4-stage worms were 
placed on each condition to test the effectiveness of each condition to rescue the 
reduced brood size B12-deficiency phenotype. The conditions used were: NGM plates 
seeded with OP50 pET-BAD btuBF E. coli grown in LB media, M9 plates seeded with 
OP50 pET-BAD btuBF E. coli grown in M9 media, M9 plates seeded with OP50 pET-
BAD btuBF E. coli grown in M9 media supplemented with 1 µM of cyanocobalamin, 
M9 plates seeded with OP50 pET-BAD btuBF E. coli grown in M9 media 
supplemented with 1 µM of pseudocobalamin, and M9 plates seeded with OP50 pET-
BAD btuBF E. coli grown in M9 media supplemented with 1 µM of BoB12. The plates 





The aims of this study were to determine the action and localisation of vitamin B12 in 
C. elegans. This was broken down into a series of smaller goals, the first being to make 
the worms B12-deficient. Once the worms were depleted of B12, several experiments 
studying the overall health and ageing of the worms were carried out. This was 
measured by studying larval development and life cycle, lifespan, fecundity, and 
neuronal health. The ability of various cobalamin analogues to rescue the B12-deficient 
worms was also tested. B12 localisation was studied by synthesising fluorescent 
cyanocobalamin and inserting it into the worms indirectly via E. coli OP50. 
M;ﾆｷﾐｪ BヱヲどSWaｷIｷWﾐデ Cく WﾉWｪ;ﾐゲ 
To understand the physiological role of B12 in C. elegans it was necessary to make N2 
C. elegans B12-deficient and compare these with those that were not. C. elegans are 
usually maintained on nematode growth media (NGM), which is seeded with E. coli 
grown in LB media. Worms grown on this condition were used as a control, as most 
published data on ageing uses this media, which allowed us to compare our results to 
the expected, verifying that our experiments had been carried out correctly. Whilst E. 
coli cannot synthesise B12 de novo, NGM and LB contain trace amounts of B12. To 
make the worms B12-deficient we grew them on M9 agar plates seeded with E. coli 
grown in M9 media so that no trace of B12 was present (M9 B12- plates). As these 
growth conditions were considerably different to the standard NGM one, we also 
compared with the M9 B12- protocol with M9 plates where B12 was supplemented back 
into the agar (100 µg/L cyanocobalamin) and seeded with the B12-deficient E. coli (M9 
B12+ plates). This allowed us to determine to what degree the effect observed was due 
to the minimal growth conditions (M9 media) or due to the lack of vitamin B12. 
One egg from the NGM plates was placed on a M9 B12+ plate (3 repeats) and allowed 
to develop and lay eggs, of which one was taken and placed on to another M9 B12+ 
plate. This was repeated for ten generations, after which the worms were used as 
controls. This process made sure that the worms were completely acclimatised to the 
condition before carrying out any experiments, which made our results less variable 
and more reliable. To make the worms B12-deficient, an egg was taken from this 
control group and placed on to an B12-deficient plate seeded with B12-deficient E. coli. 
The same procedure of allowing the egg to develop into an adult worm, and taking an 
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egg and placing it onto another B12- plate, was carried out for five generations (Fig. 4). 
After the five generations the worms were B12-depleted and were kept on the B12-
deficient media to be used as the experimental group (Bito et al., 2013). According to 
previously published data it takes five generations to make C. elegans B12-deficient 
because vitamin B12 is transported from mother to offspring via the ABC transporter 
MRP-5 (Na et al., 2018).  
 
 
Figure 4. Process of making the C. elegans B12-deficient. The B12+ condition was 
made by taking one egg from N2 C. elegans grown on NGM and placing it on to a 
M9 B12-supplemented (B12+) plate. It was allowed to develop into an egg-laying 
adult and one of its offspring was taken and placed on to a new B12+ plate. After 
10 generations these worms were used as controls. To make B12-deficient worms, 
we took one egg from the B12-supplemented control condition and placed it on to a 
non-supplemented M9 plate (B12-). After five generations these worms were 
considered B12-deficient and were used for experiments. The worms were kept at 
20˚C on each of the three conditions used in the experiments (NGM, B12+, and B12-) 
and were not mixed at any time during the duration of the study, except when 
specifically indicated. (Bito et al., 2013) 
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To confirm that we had successfully made the N2 C. elegans strain B12-deficient by 
growing them on the B12- condition, we used a superficially wild-type C. elegans strain 
that had the acyl-CoA dehydrogenase-encoding (acdh-1) gene (located on 
chromosome 1) knocked out (VC1011 acdh-1(ok1489) I.). This gene encodes the first 
enzyme in the く-oxidation-like propionate breakdown pathway (ACDH-1), which does 
not require vitamin B12. The acdh-1 promoter is induced when vitamin B12 is not 
available, demonstrating the metabolic network rewiring mechanism found in C. 
elegans (Watson et al., 2014). The acdh-1 deletion mutant C. elegans strain cannot 
survive without vitamin B12, as propionate accumulates to toxic concentrations 
intracellularly (Watson et al., 2016).  
We tested whether the media was effectively depleting the N2 worms of vitamin B12 
by using this VC1011 acdh-1-deletion strain. To make sure that the strain had the 
correct gene knocked out, several worms were genotyped. To do this, we designed 
primers for the acdh-1 gene sequence (Fig. 5a and Fig. S1 of supplemental data) and 
then carried out single-worm PCR of the acdh-1 deletion mutant strain (VC1011) and 
the N2 strain, which was used as the control. The primers were designed based off of 
the gene nucleotide sequence for the wild-type and the acdh-1(ok1489)-deletion strain 
(Fig. 5a). The expected PCR products for the N2 strain are 1190 bp with the external 
primers and 500 bp with the internal primers. For the VC1011 strain, the expected PCR 
products are 590 bp with the external primers and no product with the internal primers 
(as the 600 bp sequence of the acdh-1 gene is deleted). The results of this are seen in 
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Figure 5a and b. VC1011 (acdh-1-deletion) strain genotyping using single-
worm PCR. a. Diagram of the achd-1 gene (C55B7.4a: ACDH-1, isoform A), 
the ok1489 deletion allele, and primers (to scale). Grey rectangles indicate exons, 
and the black lines indicate introns. The dark grey rectangle indicates the position 
of the 600 bp deletion found in the VC1011 (acdh-1(ok1489) I.) C. elegans strain. 
The blue rectangles indicate the external primers and the red ones represent the 
internal primers, with arrows indicating direction. b. Images of PCR product gels. 
Gel on the left: Gel of external primer PCR products. Columns 1-4: N2 DNA with 
external primers. Columns 5-8: VC1011 DNA with external primers. Column 9: 
Blank. Column 10: WT DNA with external primers (positive control). Column 11: 
Water (ultrapure) with external primers (negative control). Column 12: Blank. 
Column 13: 1 Kb Plus DNA Ladder. Gel on the right: Gel of internal primer PCR 
products. Columns 1-4: N2 DNA with internal primers. Columns 5-8: VC1011 
DNA with internal primers. Column 9: WT DNA with internal primers (positive 
control). Column 10: Water (ultrapure) with external primers (negative control). 
Column 11: 1 Kb Plus DNA Ladder. 
The expected PCR products for the N2 strain were 1190 bp with the external 
primers and 500 bp with the internal primers. For the VC1011 strain the expected 
products were 590 bp with the internal primers and no product with the internal 




























To test whether the conditions used made our N2 worms B12-deficient we placed the 
VC1011 strain on the same conditions and treated them the same as our N2 worms. 
After five generations all of the VC1011 worms were dead, whilst the N2 worms were 
still viable (data not shown). Thus, we are confident that we have established a protocol 
to make worms B12 deficient. 
 
The physiological effects of B12 deficiency in vivo 
We then profiled the physiological effects of B12 deficiency in whole, live worms. 
There are several well characterised outputs of worm-health, out of which we 
examined those particularly focused on ageing (larval development, lifespan, and 
neurite branching, which indicates neuronal health), and fecundity. 
B12 deficiency slows larval development 
The time it takes for a worm to develop from embryo to adult is a good read out of 
overall health and fitness, and under normal growth conditions, at 20˚C, this takes 
approximately 3 days. To examine the effect of vitamin B12 deficiency on larval 
development, we synchronised a population of embryos by carrying out a timed egg 
lay, and monitored their growth over a 4-day period by measuring the length of the 
animals using light microscopy and image quantification software every 24 hours (Fig. 
6). We found that worms lacking B12 (B12-) grew slower and remained slightly smaller 
as adults that worms grown in either B12+ or NGM conditions.  Thus, we concluded 






Bヱヲ SWaｷIｷWﾐI┞ SWIヴW;ゲWゲ ﾉｷaWゲヮ;ﾐ 
Lifespan is also a well characterised attribute of nematode health, with several studied 
factors which influence it (e.g. food availability, insulin pathway signalling, and 
temperature). A healthy N2 worm grown at 25˚C on NGM with E. coli OP50 as a food 
source will typically live approximately 20 days, and a reduced lifespan indicates poor 
growth conditions (with the exception of elongated lifespan due to the stress-induced 
dauer state) (Zhang et al., 2015). To measure the lifespan of the worms on our three 
conditions, we conducted a lifespan assay, with 100 worms per assay (Fig. 7). L4 





















Figure 6. Developmental assay. Experiments were carried out at 20°C. Using a 
two-tailed T-test, all P-values were significant: Day 1: B12- vs B12+ (p=6.76498E-
08), B12+ vs NGM (p=1.89498E-18), B12- vs NGM (p=5.1683E-32). Day 2: B12- 
vs B12+ (p=1.77042E-65), B12+ vs NGM (p=6.70488E-06), B12- vs NGM 
(p=1.33606E-78). Day 3: B12- vs B12+ (p=1.72473E-51), B12+ vs NGM 
(p=0.000774796), B12- vs NGM (p=2.52165E-66). Day 4: B12- vs B12+ 
(p=2.46627E-20), B12+ vs NGM (p=0.03316559), B12- vs NGM (p=2.38518E-24). 
Worms were imaged and measured using a Leica DMR microscope and measured 
using Leica Application Suite X (LAS X) microscopy software. The experiments 
were performed in triplicate and the individual trial information can be found in 
Fig. S2 of the supplemental data. 
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plates containing FuDR to prevent the eggs from hatching (a standard technique used 
for this type of assay) and incubated at 25˚C. The worms were counted every other day 
and scored as alive, dead (when no longer responding to light touch from a worm pick), 
or censored (escaped worms or unnatural deaths, such as internal hatching). Worms 
grown on the nutrient-rich NGM media had ~20-day lifespans, as expected for this 
temperature, which indicated that the experiment had been carried out correctly. 
Worms grown on the B12+ and B12- conditions had reduced lifespans compared to the 
ones grown on the NGM condition, which was also to be expected as they were grown 
on media containing only the bare essential nutrients. However, the B12+ condition 
was significantly better off than the B12- condition, with the only difference being the 




























Figure 7. Lifespan assay. Experiments were carried out at 25°C with FuDR to 
prevent internal hatching and progeny development. The experiments were carried 
out as described above and performed in triplicate. A two-tailed T-test was carried 
out to determine the statistical significance: for the NGM vs B12+ and the NGM vs 
B12- conditions p=0, and for the B12+ vs B12- p=0.0036. This indicates a significant 
difference between all three conditions. The individual trial information can be 
found in Fig. S3 of the supplemental data. 
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The combined data shows that there is a significant difference between all three 
conditions, with the B12-deficient worms having the shortest lifespan. This is 
consistent with previously published data, although our experiments were carried out 
at 25°C vs. 20°C, and we had worms grown on NGM as a control to compare the M9 
media to the standard nutrient-rich NGM (Bito et al., 2013). Having the NGM control 
allowed us to verify whether the overall experiment was carried out correctly. The 
lifespan of the worms grown on NGM (control) correlated with previously published 
data, indicating that the assay was performed appropriately (Zhang et al., 2015). We 
concluded from these experiments that vitamin B12, is important for general health and 
lifespan, and that nutrient availability plays a large role in lifespan. 
 
Bヱヲ SWaｷIｷWﾐI┞ ヴWS┌IWゲ aWI┌ﾐSｷデ┞ 
Fecundity is another measure of nematode health, with N2-strain worms laying 
between 250 and 300 eggs at 20˚C on NGM (Hodgkin et al., 1991). To determine the 
effect of vitamin B12 deficiency on this attribute, we carried out a brood size assay. We 
transferred individual L4-stage worms to fresh plates of their corresponding growth 
medias and incubated them at 20˚C (10 per condition), transferring them each day on 
to fresh plates. This allowed us to measure not only the total amount of eggs laid 
(which hatched) (Fig. 8), but also the amount of eggs laid per day (Fig. S4 of 
supplemental data). 
A two-tailed T-test analysing the combined data shows that there is a significant 
difference between both the NGM and the B12- and the B12+ and the B12- conditions, 
but not between the NGM and the B12-supplemented condition.  The result of this test 
for NGM vs B12+ is p=0.346569706, for NGM vs B12- it is p=8.60383E-07, and for 
B12+ vs B12- it is p=2.236E-09. From these results we can conclude that there is a 
decrease in fecundity in B12-deficient C. elegans, and that it can be completely rescued 






Vｷデ;ﾏｷﾐ Bヱヲ SWaｷIｷWﾐI┞ ｷﾐIヴW;ゲWゲ ﾐW┌ヴｷデW Hヴ;ﾐIｴｷﾐｪ ｷﾐ Cく WﾉWｪ;ﾐゲ 
Neurite branching in C. elegans has been previously used as a marker for neural health 
and neurodegeneration. The increase in branching of mechanosensory neurons as 
worms age is associated with a decrease in response to touch, indicating the 
deterioration of these neurons. In addition, C. elegans is an excellent model for human 
neurodegenerative diseases, as its neural network has been completely mapped, and 
changes can be observed in vivo due to the natural transparency of these worms. 
The effect of several conditions on neurite branching in C. elegans has been studied, 
such as ageing, oxidative stress, and insulin signalling, but the effect of vitamin B12 
deficiency had not been studied until now. To determine the effect of B12 deficiency 
on neurodegeneration in these nematodes, we carried out a neurite branching assay 
using worms with GFP-tagged MEC-4 channels (CZ10175 strain). MEC-4 sodium ion 
channels are only found in the six mechanosensory neurons, which makes it easy to 
visualise and determine whether they are branched or not. The physiology of healthy, 






























Figure 8. Brood size assay. Graph shows the average total amount of eggs laid by 
an individual worm at 20°C on each condition. The experiments were performed in 




has been previously determined, and they appear linear and smooth (Fig. 9) (Suzuki et 
al., 2003). As worms age, the neurons develop random ‘blebbing’ (which appears as 
dots along a thinner axon), zig-zagging axons, and neuronal branching, which 
especially occurs at the cell body and at ‘blebs’.  
 
A timed egg lay was carried out to synchronise the worms, which were then aged at 
20˚C and imaged on days 1, 8, and 15 of adult-stage on a Leica DMR fluorescent 
microscope to observe their rate of ageing. Worms were categorised as either positive 
or negative for neuronal branching each day, and the percentage of worms with 
neuronal branching was calculated, which gave us an indication of the degree of 
overall neural health in each population at each timepoint. Representative images of 
the structure of the neurons on each day for each condition can be found below (Fig. 
10). As can be observed, the B12-deficient worm neurons are significantly more 
deteriorated by adult day 8 compared to the neurons of the worms on the NGM or the 
B12+ conditions. Moreover, by day 15, many of the worms are dead by this age, and 
most of the B12-deficient worms which are alive have severe, widespread neurite 
branching. 
Figure 9. Images of fluorescent mechanosensory neurons of an adult C. elegans 
expressing the reporter gene mec-4p::GFP. A. Left lateral view. B. Ventral view. 
ALML: anterior lateral MT cell (left). ALMR: anterior lateral MT cell (right). 
AVM: anterior ventral MT cell. PLML: posterior lateral MT cell (left). PLMR: 
posterior lateral MT cell (right). PVM: posterior ventral MT cell. NR: nerve ring. 





Figure 10. Neurite branching assay images. Worms were imaged on a Leica 
DMR fluorescent microscope (GFP filter) at 20x magnification at day 1, day 8, and 
day 15 of adult stage. White arrows indicate neuronal branches. Worms were first 
observed at 10x magnification. Worms that had visible neuronal branching at this 
magnification were scored as positive for neurite branching, and those that did not 
were scored as negative. Branches were then imaged at 20x magnification, showed 
above. ‘Blebbing’ and degree of zig-zagging were not taken into account in this 
experiment. Experiments were performed in triplicate and individual trials can be 
found in the supplementary data. A worm strain containing a mec-4p::GFP 
translational fusion was used to view the mechanosensory neurons (as the MEC-4 
ion channel protein is only expressed in those six neurons). Scale bar: 50 µm. 












The results of the neurite branching assay were quantified as the percentage of worms 
that presented neurite branching on adult day 1, 8, and 15 (Fig. 11). The results of the 
T-test indicate that there is a significant difference when comparing both the NGM 
and B12+ conditions to the B12- condition, but not between the NGM and the B12+ 
conditions. The B12-deficient worms were found to have earlier-onset, as well as more 
severe neurite branching overall. Therefore, we can conclude that vitamin B12 is 
important for the maintenance of neuronal health in these nematodes, and that B12 







































Figure 11. Neurite branching assay. Carrying out a two-tailed T-test of the data, 
on day 1 there was no significant difference between and of the conditions. On day 
8 there was a significant difference between both the NGM and B12- conditions (P-
value = 0) and the B12+ and the B12- conditions (P-value = 0.0001), but not between 
the NGM and the B12+ conditions (P-value = 0.48392). On day 15, the results were 
the same: a significant difference between NGM and B12- (P-value = 0) and B12+ 
and B12- (P-value = 0), but no significant difference between NGM and B12+ (P-
value = 0.33204). Experiments were performed in triplicate and the raw data from 
each trial can be found in Fig. S7 of the supplemental data. 
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Uゲｷﾐｪ デｴW ┘ﾗヴﾏ ;ゲ ; ﾏﾗSWﾉ デﾗ ┌ﾐSWヴゲデ;ﾐS Bヱヲ ┌ヮデ;ﾆW ;ﾐS ﾉﾗI;ﾉｷゲ;デｷﾗﾐ 
As B12 comes from the diet, understanding how it is absorbed into an organism and 
identifying the tissues in which B12 it localises to is important for understanding its 
function. In humans this has been previously studied, albeit not completely discerned 
(Kozyraki et al., 2013). However, the uptake and transport mechanisms, as well as the 
final localisation of vitamin B12 in C. elegans is not well described. This is important 
as there are parasitic worms which cause vitamin B12 deficiency, and by studying the 
uptake of B12 in C. elegans we may learn more about how they compete for B12 in the 
intestine, and might discern a target against this. By synthesising a fluorescent B12 
molecule we can observe the uptake and localisation of this molecule in vivo, as these 
nematodes are inherently transparent. Fluorescent cyanocobalamin has previously 
been found to localise to coelomocyte cells in C. elegans (Lawrence et al., 2018).  
There are six coelomocytes in C. elegans, which are found in pairs in the head, 
midbody, and tail of the animal. While these cells are fixed in the worm’s body, they 
are thought to have immune and scavenging functions, as they are capable of taking 
up and accumulating various macromolecules by endocytosis, however they are not 
capable of phagocytosis. 
The aim of this previous experiment was to determine whether the fluorescent 
cobalamin analogues could be made and whether they would be taken up by a variety 
of organisms. Here, we wanted to expand on this by testing whether worms deficient 
in B12 altered the uptake or end point location of the fluorescent B12. In other words, if 
cells show a preference for regular B12 that overrides the uptake and/or use of the 
fluorescent analogues. We first synthesised the fluorescent cyanocobalamin using 
BODIPY® TR-X as a fluorophore (Fig. 12). This particular fluorophore was used due 
to its excitation in the red spectrum (excitation: 588 nm, emission: 616 nm), as C. 
elegans autofluoresce in the blue/violet area of the spectrum (Martin et al., 2002). This 





BODIPY-B12 was synthesised by linking the BODIPY® TR-X fluorophore to 
cyanocobalamin, as described previously (Lawrence et al., 2018). The ribose-5’-
hydroxyl group of cyanocobalamin was activated with 1,1'-Carbonyldiimidazole (CDI) 
(McEwan et al., 1999; Lee and Grissom 2009). This was coupled with 1,2-
Diaminoethane, which formed a primary amine at this location (Fig. 13). This allowed 
us to attach the BODIPY® TR-X to the cyanocobalamin at the correct point, as it is 
an amine-reactive dye. Once the reaction was complete, as it only had a rate of about 
50%, we used several rounds of HPLC to purify it. 
Figure 12. BODIPY® TR-X fluorescent dye molecule. The molecule has a 
seven-atom aminohexanoyl spacer (“X”) separating the amine-reactive NHS ester 
(right side) from the fluorophore (left side). The NHS ester can be used to label the 
primary amines (R-NH2) of molecules. The spacer separates the fluorophore from 





































































































































The product was subsequently purified several times to ensure the purity of the sample: 
first by semi-preparative HPLC and subsequently by preparative HPLC-MS. The 
purification allowed us to remove large amounts of impurities, whilst the preparative 
HPLC-MS enabled us to separate the regular cyanocobalamin from our fluorescent 
BoB12 sample as much as possible, as well as carrying out mass spectrometry to 
confirm that we had synthesised the right product (Fig.14). As we were primarily 
testing whether BoB12, in the absence of B12, would localise to somewhere other than 





Figure 13. Diagram of the chemical synthesis of BODIPY® TR-X ribose-
linked cobalamin. The BoB12 was synthesised as described previously. (Lawrence 







To compare the preference in uptake of B12 and BoB12, we studied the uptake of the 
fluorescent cyanocobalamin on the B12-deficient worms grown on our solid M9 media 
by introducing BODIPY-B12 into E. coli and then feeding it to the worms. To do this 
E. coli OP50 was transformed with a pET-BAD plasmid containing the btuB and btuF 
genes and used as an intermediary to transfer the BoB12 to the worms, as described 
previously (Lawrence et al., 2018). BtuB is an outer membrane E. coli protein that 
actively transports B12 analogues indiscriminately into the periplasm. The trans-
periplasmic protein TonB interacts with BtuB to drive the reaction (Cadieux and 
Kadner, 1999). Calcium increases the affinity of cyanocobalamin for BtuB by a factor 
of 50 to 100 (Chimento et al., 2003). Overproduction of BtuB in E. coli increases the 
amount of B12 uptake (Heller et al., 1985). BtuF is a periplasmic protein also involved 
in CNCbl uptake (Cadieux et al., 2002). 
Figure 14. HPLC-MS of BODIPY® TR-X ribose linked cobalamin (BoB12).   
Results from sample run on HPLC-MS, which was later used in our localisation 
and rescue experiments. The UV absorbance curve has peaks at the expected 
wavelengths: ~361 nm for cyanocobalamin and 588 nm for BODIPY® TR-X. The 
m/z also correlated with the expected results. More detailed information can be 




To induce the E. coli to take up as much of the fluorescent cyanocobalamin as possible, 
it was transformed with a pET-BAD btuB-btuF vector (Fig. S6 of supplemental data). 
This increased the amount of BtuB and BtuF transporters in each bacterium, 
maximising BoB12 internalisation.  
The E. coli containing the btuBF pET-BAD plasmid was grown in the dark as indicated 
in the methods section. To verify that the BODIPY-B12 had been taken up by the E. 
coli, the cultures were spun down and washed three times in M9 media to remove any 
BoB12 that had not been taken up. After this, the pellet was resuspended in M9 media 
and imaged on an Olympus IX-81 inverted fluorescence microscope at 100x 




Figure 15. Image of btuBF pET-BAD plasmid-expressing E. coli containing 
BoB12. BoB12 was introduced into the E. coli as described previously by Lawrence 
et al. (2018). Cells were imaged on an Olympus IX-81 inverted fluorescence 
microscope at 100x magnification using an RFP 580 filter. Brightfield images were 
then overlaid with the fluorescence images to confirm colocalisation of BoB12 and 
E. coli, verifying the uptake of BoB12. The white arrows point to the OP50 E. coli 
cells which have taken up the fluorescent cyanocobalamin (approx. 6%). 
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Once it was confirmed that the BoB12 had been internalised by the BtuBF-
overexpressing E. coli, non-B12-supplemented M9 agar plates were seeded with the 
culture to be used in the B12-localisation study. L4 stage worms were placed on to these 
plates and incubated at 20°C. Three days later, the now-adult progeny was imaged. All 
reactions and procedures involving the BoB12 analogue, including incubation of plates 
and worms, were performed in dark/low light conditions. Overlaying the brightfield 
images with the fluorescent ones, we concluded that the fluorescent B12 localised to 
the coelomocytes (Fig. 16).  
          
From the results obtained, we can conclude that BODIPY® TR-X ribose linked 
cobalamin localises to the coelomocyte cells even in B12-deficient C. elegans. The 
confirmation that the worms were able to take up this cobalamin analogue supports 
the previously described method that this technique can be used to tag and follow 
macromolecules in vivo. In addition, it shows that worms do not necessarily have a 
preference for regular cyanocobalamin.  
We then tried a different method to study the localisation of the BoB12 in worms, to 
see whether the state of the media had any effect in the uptake of this molecule. We 
attempted introduced the fluorescent cyanocobalamin into the worms by incubating 
them in axenic liquid media (prepared as described previously by Samuel et al., 2014), 
Figure 16. BoB12 localisation to the coelomocytes in adult C. elegans. Arrows 
point to coelomocyte cells. A: Head section coelomocyte pair of two C. elegans. 
B: Midbody coelomocytes (black arrow points to vulva for reference). C: Tail 
coelomocyte pair. Worms were imaged on an Olympus IX-81 inverted fluorescence 
microscope at 60x magnification using an RFP 580 filter, on 2% agarose pads with 
0.06% tetramisole hydrochloride to immobilise the worms. Brightfield images were 
then overlaid with the fluorescence images to confirm the localisation of the BoB12 
to the coelomocytes. 
A B C 
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supplemented with 3.3µM of BoB12. In contrast to our previous work on solid media 
however, we noted that the majority of the fluorescent B12 analogue became stuck in 
the nematode’s mouth (Fig. 17), by which we concluded that the protocol designed by 
Lawrence et al. (2018) was more effective at introducing the fluorescent cobalamin 
analogue into the worm. 
    
 
RWゲI┌ｷﾐｪ デｴW BヱヲどSWaｷIｷWﾐデ ヮｴWﾐﾗデ┞ヮW ┘ｷデｴ IﾗH;ﾉ;ﾏｷﾐ ;ﾐ;ﾉﾗｪ┌Wゲ 
With the B12-deficiency phenotype established and with a certain degree of confidence 
that the BoB12 can be taken up into the worm (Fig. 16), we tried rescuing the 
physiological phenotypes associated with B12 deficiency with the fluorescent B12 
analogue to determine its ability to function as normal B12. For this we compared it 
with cyanocobalamin, as well as pseudocobalamin. Pseudocobalamin is produced by 
some bacteria, especially cyanobacteria, but significantly it is not bioactive in humans. 
We included it in our rescue experiment as we wanted to investigate whether this 
molecule is biologically active in the nematodes. This would be an interesting find 
regarding parasitic nematode worms and their ability to utilise pseudocobalamin 
ingested through diet from other foods. We tried rescuing the reduced brood size 
phenotype of B12-deficient C. elegans as it had consistent results across all three trials 
and was significantly reduced when compared to the NGM and B12+ conditions. 
Figure 17. Adult C. elegans grown in liquid axenic media supplemented with 
BoB12. Arrows point to the mouths of the nematodes, where fluorescence can be 
seen, indicating that the fluorescent B12 analogue is caught in the worm’s mouth. 
Worms were imaged at 40x magnification. 
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To create the five conditions and maintain them as comparable as possible, we used 
the OP50 containing the pET-BAD btuBF plasmid in all of them, and the cobalamin 
analogues were all added to a final concentration of 1 µM, along with arabinose to 
induce their uptake. For the first condition, we used NGM plates seeded with the 
plasmid-containing OP50 grown in LB. The other four conditions used non-
supplemented M9 agar plates. In the second condition, we seeded the plates with the 
OP50 grown in minimal E. coli M9 media, which acted as a negative control with no 
B12 present. For the final three testing conditions we grew the plasmid-expressing 
OP50 E. coli in M9 media supplemented with either cyanocobalamin, 
pseudocobalamin, of BODIPY® TR-X ribose-linked cyanocobalamin. 
For the cobalamin analogue brood size rescue experiment, B12-deficient nematodes 
were transferred at stage L4 from the B12-deficient M9 media to the five different 
conditions, which tested the ability of each media to rescue the decreased brood size 





























Figure 18. Reduced brood size B12-deficiency phenotype rescue experiment 
with cobalamin analogues. Only the difference between the NGM and all other 
conditions is significant with a two-tailed T-test (NGM vs B12- p=3,56364E-05; 
NGM vs B12+ p=4,70571E-06; NGM vs pseudocobalamin p=1,02448E-07; NGM 
vs BoB12 p=1,98521E-08). Experiments were performed in triplicate and the 
individual trials can be found in Fig. S8 of the supplemental data annex. 
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From this we can conclude that placing the B12-deficient worms at stage L4 on the 
different medias did rescue the decreased fertility of the B12-deficient worms. We 
cannot say with certainty whether the pseudocobalamin and BoB12 analogues are 
bioactive in the worms and if they would rescue the B12-deficiency phenotype from 
the results of this experiment. The NGM condition did rescue the decreased brood size 
characteristic of B12-deficient worms, however this media is very rich in nutrients 
compared to the M9 media that the other conditions are based upon. We could 
postulate that it is a matter of the worms not being incubated for long enough on the 
other conditions, as it has been previously determined in our other brood size 
experiments that worms grown permanently on the B12+ do have normal, healthy 







The goal of this project was to investigate the effects of vitamin B12 deficiency in C. 
elegans, and to study the localisation of this vitamin in vivo. In addition, the ability of 
pseudocobalamin and various cobalamin analogues to rescue the B12-deficient 
phenotype was studied. The B12-deficiency phenotype included delayed life cycle, 
shortened life span, reduced fertility, and neuronal deterioration. 
 
Eゲデ;Hﾉｷゲｴｷﾐｪ ; ヮヴﾗデﾗIﾗﾉ aﾗヴ ヮヴﾗS┌Iｷﾐｪ Bヱヲ SWaｷIｷWﾐデ ┘ﾗヴﾏゲ 
The main goal was broken down into smaller aims, the first being to determine a 
protocol for producing B12-deficient C. elegans at the University of Kent. C. elegans 
was made vitamin B12-deficient by growing them on minimal M9 media with E. coli 
grown in M9 media as a food source. The ability of our media to make the worms B12-
deficient was confirmed with an acdh-1-deletion strain of C. elegans, which cannot 
survive on B12-deficient media (Watson et al., 2016). Our results indicated that by the 
fifth generation, which is when we started using the N2-strain worms for experiments, 
all of the acdh-1-deletion strain worms were dead. This result confirmed that B12-
deficiency can be induced in C. elegans, and that it can be produced in a relatively 
short period of time. 
 
DWデWヴﾏｷﾐｷﾐｪ デｴW ヮｴWﾐﾗデ┞ヮｷI WaaWIデ ﾗa ┗ｷデ;ﾏｷﾐ Bヱヲ SWaｷIｷWﾐI┞ ｷﾐ Cく WﾉWｪ;ﾐゲ 
The second aim was to study the phenotype generated by vitamin B12 deficiency in C. 
elegans. We carried out experiments confirming previously published data on B12 
deficiency in these nematodes (delayed life cycle, reduced fertility, and reduced 
lifespan), as well as studied new phenotypes associated with this condition (Bito et al., 
2013). It is to note that previously published results did not use worms grown on NGM 
as a control (Bito et al., 2013), which made it difficult to elucidate which effects were 
a result of the worms being grown on minimal media and which were actually caused 
by a deficiency of vitamin B12, as well as if the experiments had been carried out 
correctly (as there are no previous studies determining the expected results). In 
addition, from those studies, we could not confirm whether the B12-supplemented 
condition was rescuing the worms to the level of those grown on standard, nutrient-
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rich NGM or just partially ameliorating the symptoms of B12 deficiency. We wanted 
to confirm these results, as well as expand on them, particularly focusing on the role 
of B12 in ageing. 
The first set of experiments studied the nematode’s life cycle and developmental rate. 
The results indicate that B12-deficient worms take approximately one day longer to 
develop from an egg to adult stage, and that supplementing the M9 media with vitamin 
B12 completely rescues this delayed lifecycle phenotype to the same levels as worms 
grown on nutrient-rich NGM. This is consistent with previously published findings, 
however our results also indicate that the B12-supplemented condition rescued the 
worms completely, with no significant difference between it and the NGM condition 
(Bito et al., 2013). From this, we can conclude that B12 is important in larval 
development. 
Lifespan experiments were then carried out with FuDR at 25°C which, from 
experience, reduces the amount of internal hatching seen at 20°C. The first two trials 
were found to have a significant difference between the NGM condition and the B12-
deficient condition, but not between the B12-supplemented and the B12-deficient 
condition. However, both the last trial and the combined data were found to have a 
significant difference between all three conditions. The results from the first two trials 
could have been due to human error, as these were the first experiments carried out. 
However, the results are inconclusive, and more trials should be carried out to verify 
them. It was to be expected that the worms grown on the minimal media would be 
worse off than those grown on the nutrient-rich NGM plates, however supplementing 
with B12 seemed to partially restore this. Our experiments were carried out at 25°C 
compared to previously published data, which performed them at 20°C and showed 
that B12-deficient worms had a shorter lifespan compared to the ones that had vitamin 
B12 supplemented in the media (Bito et al., 2013). We note that this previously 
published paper does not have the standard NGM media as a control for the minimal 
media agar plates, which, as our results show, prevented them from painting the whole 
picture: that although supplementation with cyanocobalamin alleviates the detrimental 
symptoms of B12-deficiency on lifespan, it cannot rescue them to normal levels. These 
results indicate that while vitamin B12 may play a part in longevity, general nutrient 
availability has a more important role in regulating lifespan. 
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Fecundity, another marker of nematode health, was measured via brood size assay, 
which determines the number of viable offspring laid by each worm. Our results show 
that the B12-deficient worms have a significantly reduced brood size, and that the 
worms grown on the B12-supplemented condition had no significant difference with 
the NGM condition. These results indicate that B12 is important in fecundity and that 
it can rescue the decreased fertility associated with B12-deficiency to normal levels. 
Whilst this correlates with previously published data in that B12-deficient worms have 
reduced brood sizes compared to those grown on B12-supplemented M9 media, 
previously published data shown extremely low numbers of eggs laid (approx. 85 
eggs/worms for the B12-supplemented M9 condition and approx. 55 eggs/worms for 
the non-supplemented M9 condition), as well as no NGM control (Bito et al., 2013). 
Having the NGM condition as a control allowed us to verify whether the reduced brood 
size effect was due to B12-deficiency or the nutrient-poor minimal media, as well as if 
the experiment was carried out correctly (as the average number of eggs N2 WT C. 
elegans lay on NGM media at 20°C is thoroughly studied). The results of our NGM 
condition indicate that our experiment was carried out correctly, as N2 worms lay an 
average of 250-300 eggs at 20°C (Hodgkin et al., 1991). In addition, while our B12-
deficient brood size was much lower than our control brood sizes (approx. 150 
progeny/worm compared to 250 progeny/worm in the controls), it was still 
significantly higher than the published data. Thus, the previously published results 
clash with our findings, where the B12-supplemented condition was rescued 
completely to the level of the NGM condition, and there are very low numbers of eggs 
laid per worm compared to our results. This raises the question of whether the 
previously published data on the effect of B12 deficiency on brood size is correct. More 
fecundity experiments should be carried out to corroborate this. 
 
Uゲｷﾐｪ ┘ﾗヴﾏゲ デﾗ ﾏﾗSWﾉ デｴW ヴﾗﾉW ﾗa Bヱヲ ｷﾐ ﾐW┌ヴﾗSWｪWﾐWヴ;デｷﾗﾐ 
Whilst C. elegans is used as a model for several neurodegenerative diseases, and 
neurite branching has been defined as a marker for neurodegeneration, the effects of 
B12 deficiency on neural health in this organism had not been studied. This study 
reports that B12-deficiency in C. elegans increases neuronal ageing, and that this can 
be rescued by supplementing the media with cyanocobalamin. 
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B12 is known to impact on neuronal integrity and function in humans (Savage, 1995; 
Kocer, 2009; Chien Tu et al., 2017; Irevall, 2017). To explore the possibility that this 
could be studied at the molecular basis in worms we examined the effect of B12 
deficiency on neurite branching in ageing worms. In worms, neurite branching can be 
correlated with neuronal ageing and deterioration. To examine the role of B12 in 
neuronal health and ageing, we used CZ10175 strain C. elegans, which have a zdIs5 
transgene containing a mec-4p::GFP translational fusion, which allows us to view the 
mechanosensory neurons (as MEC-4 is only present in these six neurons). A neurite 
branching assay was carried out by performing a timed egg lay and imaging the 
CZ10175 worms 3 days later, which was day 1 of adult stage. It is to note that most of 
the B12-deficient worms were at L4 stage at day 3 post-timed egg-lay, however this 
was the most accurate was of synchronising the worms. Even though the B12-deficient 
worms arrived at adult stage after the worms on the B12-supplemented and NGM 
conditions, they presented neurite branching earlier on and more severely than the 
others. These results show us that C. elegans can be used as a model for the neuronal 
effects of vitamin B12 deficiency, as B12 has been shown to impact on neuronal 
integrity and function in humans (Savage, 1995; Kocer, 2009; Chien Tu et al., 2017; 
Irevall, 2017). In addition, our results indicate that B12 deficiency increases the onset 
and severity of neuronal ageing and deterioration in these worms. 
C. elegans is often used as a model for neurodegenerative diseases, of which a large 
part are tauopathies (e.g. Alzheimer’s disease) (Li and Le, 2013; Wang et al., 2018). 
The aggregation of filamentous tau is the second hallmark of Alzheimer’s disease, 
where they form neurofibrillary tangles (Shirafuji et al., 2018). Protein with tau-like 
repeats-1 (PTL-1) is the homologue of mammalian tau and MAP2 in C. elegans and 
regulates neuronal health (deviation from WT levels is detrimental to the worms) 
(Gordon et al., 2008; Chew et al., 2013; Chew et al., 2014; Chew, Götz and Nicholas, 
2014). Previous studies have shown that hyperphosphorylated tau aggregation causes 
morphological abnormalities in mechanosensory neurons in C. elegans (Kraemer et 
al., 2003; Miyasaka et al., 2005; Miyasaka et al., 2016, Miyasaka et al., 2018). Vitamin 
B12 was found to bind to tau cysteine residues, preventing tau fibrillation and further 
aggregation, which suggests another way that cobalamin prevents neural degeneration 
(Rafiee et al., 2017). Alzheimer’s is a tauopathy caused by protein aggregation, and 




Cobalamin deficiency also causes accumulation of homocysteine 
(hyperhomocysteinemia), which has been classified as a risk factor for 
neurodegenerative diseases, such as Alzheimer’s disease and dementia (Werder, 2010). 
When C. elegans become B12-deficient, MeCbl is not available as a cofactor for 
methionine synthase (MS), and homocysteine cannot be converted to methionine (Fig. 
19), which causes the accumulation of homocysteine in the cytosol. Homocysteine has 
recently been shown to increase the amount of tau protein and its phosphorylation, 
oligomerisation, and aggregation, all of which are associated with cell toxicity 
(Shirafuji et al., 2018). 
 
 
Fﾉ┌ﾗヴWゲIWﾐデ Bヱヲ ﾉﾗI;ﾉｷゲWゲ デﾗ デｴW IﾗWﾉﾗﾏﾗI┞デWゲ ｷﾐ ┘ﾗヴﾏゲ 
Whilst B12 absorption and transport has been studied in humans, there is still little-to-
no information for the model organism C. elegans. These nematodes cannot be used 
as a model for B12 absorption in humans, as the main B12-binding proteins in humans, 
intrinsic factor (IF) and transcobalamin, have not been seen in C. elegans. However, 












Figure 19. Simplified diagram of the SAM cycle. Methionine synthase (MS) 
catabolises the reaction of homocysteine to methionine in the cytosol, using MeCbl 
as a cofactor. B12-deficiency inactivates MS, consequently causing the 






compete for the uptake of vitamin B12 in the small intestine, as well as corroborate a 
new method for tracking macromolecules in vivo using fluorophores. Lawrence et al. 
(2018), showed that BODIPY® TR-X ribose linked cobalamin (BoB12) localised to 
the coelomocytes in these nematodes. There are six coelomocytes cells in C. elegans, 
which are thought to carry out immunological and scavenging functions (Fares and 
Grant, 2002). They are able to endocytose a wide variety of macromolecules and have 
high lysosome biogenesis rates, however, unlike macrophages, they are incapable of 
carrying out phagocytosis (Treusch et al., 2004; Ewbank, 2002). These cells are 10-15 
µm in diameter and have a fixed position in the worm, with two localising to the head 
region, two to the midbody, and two to the tail end, meaning that the material it takes 
up must be transported there. In addition, coelomocytes have been found to not be 
essential for the growth or survival of the nematodes (Fares and Greenwald, 2001). 
The localisation of BoB12 to the coelomocytes even in B12-deficient C. elegans may 
indicate that it is not being recognised as vitamin B12 or that the fluorophore is being 
cleaved off when cyanocobalamin is converted to MeCbl or AdoCbl in the worm. 
Alternatively, C. elegans only need trace amounts of vitamin B12 to survive. The 
fluorescent B12 may be localising to other cells in minute amounts, with the excess 
being endocytosed by the coelomocytes. The concentration of fluorescence in the 
coelomocytes, paired with the gut autofluorescence of C. elegans, may cause the few 
molecules of BoB12 localising to other cells to be overlooked. Alternative tests such as 
immunostaining could be carried out to verify the localisation of B12 in the worms. 
However, the fact that the fluorescent B12 was absorbed and transported in the worm 
corroborates the results published by Lawrence et al. (2018), showing that 
fluorophores could be used to tag macromolecules to follow them in vivo in C. elegans. 
 
RWゲI┌W ﾗa BヱヲどSWaｷIｷWﾐI┞ ヮｴWﾐﾗデ┞ヮW ┘ｷデｴ IﾗH;ﾉ;ﾏｷﾐ ;ﾐ;ﾉﾗｪ┌Wゲ 
To test whether vitamin B12 deficiency could be rescued, we carried out a brood size 
rescue experiment with a variety of cobalamin analogues. To test whether the BoB12 
was bioactive, we included it in this experiment. Vitamin B12-deficient L4-stage 
worms were transferred to five different conditions: NGM, B12- (no B12), B12+ 
(cyanocobalamin), pseudocobalamin, and BoB12. The conditions containing the 
analogues were supplemented by seeding B12-deficient M9 media plates with btuBF 
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OP50 E. coli grown in culture with 1 µM of each analogue. This was done due to 
minute amounts of BoB12 and pseudocobalamin available, which did not allow us to 
supplement the agar with high concentrations of the molecules. Comparing the number 
of eggs laid in the rescue experiment with the normal brood size (where the worms 
were grown continuously on each condition), only the NGM condition rescued the 
brood size to normal levels. All other conditions (M9 media supplemented with 
cobalamin analogues and pseudocobalamin) did not rescue this detrimental phenotype.  
As we saw that worms grown permanently on B12-supplemented M9 media were 
rescued (fig. 5), we may infer that transferring B12-deficient worms at the L4 stage 
does not give them enough time to be rescued by the time they develop into the adult 
stage and begin laying eggs. Another reason for the conditions not rescuing the B12-
deficiency phenotype is that supplementing the worms’ food source rather the solid 
media has a different phenotypic effect. This experiment could be repeated by 
transferring the worms at an earlier stage or carrying out a timed egg-lay. 
Unfortunately, pseudocobalamin and BoB12 are scarce, and maintaining strains on 
media containing these molecules for extended periods of time is not viable. From this 
experiment, we can conclude that the availability of a rich source of nutrients can 
rescue the B12-deficiency-induced phenotype of decreased fertility in a very short 






We set out to study the physiological effect of vitamin B12 deficiency, as well as the 
localisation of B12, in C. elegans. In addition, the ability of pseudocobalamin and 
various cobalamin analogues to rescue the B12-deficient phenotype was tested. 
Here, we have demonstrated the physiological relevance of B12 in larval development, 
fecundity and normal lifespan. In addition, for the first time, we demonstrate a role for 
B12 in maintaining neuronal integrity during the ageing process. These studies, 
combined with the fact that we can also generate fluorescent cobalamin that can be 
taken up and stored in the worm, means that the Tullet and Warren laboratories can 
move forward and use the worm as a whole organism model to further understand the 
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Red: mutation, yellow: flanking sequence, blue: external primers, green: internal 
primers. 
〉acdh-1(ok1489) genomic secuence 
















WT genomic sequence 




























5’ external primer: gaatacggaggctctggatcctc 
3’ external primer: gttgatgttgcaaccttgaaac 
5’ internal primer: CTCAGAATCAGGTGCTGGATCCG 
3’ internal primer: GATCGAAACAACCCTGAGCCAG 
Figure S1. VC1011 (acdh-1-deletion) strain genotyping using single-worm 
PCR. Figure shows the ok1489 gene transcripts of the VC1011 and the wildtype 
strains, as well as the primers designed for the PCR. The expected PCR products 
for the N2 strain were 1190 bp with the external primers and 500 bp with the 
internal primers. For the VC1011 strain the expected products were 590 bp with the 




Worm B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM
1 322,7 367,74 353,37 590,24 719,65 823,68 914,76 1103,63 969,05 1057,21 1019,36 1198,94
2 415,7 345,83 445,81 537,95 688,64 776,47 1000,76 1130,78 1070,03 1104,98 1010,53 1146,6
3 432,98 353,21 346,38 532,88 624,09 691,66 920,94 1107,01 1037,49 1183,25 1064,5 1133,89
4 297,19 358,91 419,77 460,22 666,19 815,07 843,03 1005,49 1001,12 1083,01 1183,19 1006,7
5 288,68 358,55 382,92 503,97 797,59 740,65 879,98 1182,31 1140,61 1111,51 1162,81 1110,69
6 312,61 426,44 357,76 544,72 697,89 660,93 935,6 1117,07 822,5 1073,15 1074,68 959,08
7 469,61 344,54 388,78 647 728,95 787,44 923,23 1104,93 982,6 1012,87 982,48 1002,11
8 310,92 322,47 425,89 520,18 561,6 578,6 862,22 1054,82 958,8 1093,69 1089,12 1001,86
9 341,39 404,24 316,1 501,41 720,04 591,43 840,15 1327,97 1028,16 1017,09 992,77 1209,83
10 303,08 426,69 380,48 548,23 648,67 615,65 922 1125,61 959,27 1027,58 1174,41 962,83
11 288,09 538,05 678,25 741,29 887,66 1149,87 1014,2 1141,61 1239,1 1100,62
12 501,43 636,01 789,6 850,86 1037,94 881,49 1041 1312,59 1135,77
13 494,68 642,16 788,46 922,66 1014,91 922,62 1134,76 1121,43 1121,91
14 488,47 684,29 630,44 1101,04 941,59 1069,72 1160,66 1165,31
15 704,9 735,97 968,1 941,76 1117,9 1109,07 1337,41
16 577,49 1018,77 1088,78 1191,98 1082,35
17 626,84 1078,78 1026,4 1188,57 1124,48
18 890,47 1111,44 1243,86 1140,89
19 1121,84 1019,11 1329,48 1068,25









Average 343,90455 370,862 381,726 529,245 679,928 704,21588 900,29615 1084,299 978,086 1102,1982 1139,5047 1114,764
























Worm B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM
1 293,64 362,72 367,74 473,01 737,41 786,38 887,26 1125,73 999,52 1134,04 1198,54 1350,06
2 277,56 307,33 384,4 484,34 740,34 749,26 897,34 1114,83 1061,49 1114,71 1166,43 1144,45
3 279,11 337,55 369,47 474,95 776,09 723,51 903,27 1088,14 1015,55 1052,05 1052,88 1305,8
4 284,92 327,52 349,27 551,06 800,04 715,14 883,57 1032,79 1037,88 1208,76 1283,98 1187,11
5 300,92 317,49 390,52 488,84 722,85 744,69 929,3 1152,91 1191,38 1031,44 1096,7 1166,56
6 305,47 326,33 359,48 504,14 727,14 751,74 898,8 1093,51 1107,32 1010,59 1100,16 1163,93
7 267,11 331,46 397,36 516,55 728,63 756,97 935,35 1080,8 1127,75 1097,25 1032,26 1112,99
8 294,45 317,57 394,96 533,45 789,05 755,27 909,32 1007,5 1050,05 1065,11 1023,96 1185,92
9 301 337,47 393,23 580,23 649,14 733,91 991,95 1100,96 1035,26 965,15 1130,31 1097,45
10 289,81 337,51 393,15 509,99 673,19 736,79 871 1019,89 1062,8 1113,8 1099,57 1184,49
11 281,78 448,43 406,82 450,61 719,9 718,23 912,48 1100,38 1248,22 1035,79 1089,09 1088,9
12 280,22 336,06 389,21 527,4 885,65 745,06 879,34 1088,77 1015,93 1220,82 1119,56 1085,46
13 333,16 320,18 388,48 532,18 757,23 800,3 939,17 1096,57 1142,85 987,06 1136,44 1005,91
14 294,98 364,98 390,14 539,23 756,84 789,38 959,48 1033,05 1158,89 1082,44 1107,2 1161,51
15 273,14 333,49 395,44 474,76 727,7 789,09 887,57 1108,83 1018,15 1021,98 1169,01 1178,13
16 268,96 326,71 389,43 462,05 656,45 759,48 858,93 1093,09 1185,61 1050,38 1105,24 1255,73
17 273,51 334,01 449,27 484,8 734,32 786,2 891,35 1043,46 1097,88 1113,03 1068,48 1214,7
18 262,65 317,87 423,57 591,23 724,42 720,82 921,83 1127,92 1213,56 963,51 1120,34 1166,3
19 280,47 343,97 427,66 490,98 715,61 819,18 893,7 1092,86 1038,19 1105,59 1185,34 1049,51
20 281,09 349,45 449,96 520,82 689,37 640,37 846,48 1009,33 1089,7 1045,53 1103,09 1149,83
21 292,43 338,26 406,81 422,23 742,15 664,43 969,59 1135,56 1155,46 1054,42 1338,12 1127,43
22 275,97 312,09 407,49 476,56 776,84 766,27 860,08 1244,45 1172,48 1101,75 1095,46 1144,36
23 293,8 355,3 405,42 508,55 781,32 766,15 885,74 1205,14 1077,76 1168,98 1274,01 1214,19
24 288,3 319,12 381,49 539,71 620,22 767,58 829,41 999,76 1080 1048,49 1109,02 1078,13
25 302,85 348,77 415,62 496,78 725,88 713,75 906,28 1023,02 1066,36 1041,45 1220,31 1141,98
26 283,27 355,2 365,91 501,94 625,16 790,92 907,06 1028,06 1093,73 1107,46 1227,81 1136,12
27 365,94 401,47 505,57 798,11 735,48 872,34 1082,98 1044,51 1058,13 1244,84 1186,62
28 314,29 400,83 544,8 638,78 783,37 854,51 1066,56 1035,14 1093,5 1260,48 1291,44
29 347,1 399,2 530,3 784,42 682,01 833,91 1103,61 1031,17 1043,17 1145,13 1139,12
30 363,2 444,08 640,7 821,26 672,91 895,68 974,49 1038,21 1007,13 1306,83 1258,84
31 354,43 379,43 473,94 686,09 771,51 826,72 1052,9 1034,83 1001,5 1174,13 1244,24
32 392,68 499,36 664,25 775,18 858,56 1026,99 1006,36 1041,09 1261,37 1190,03
33 408,19 516,03 701,49 792,33 840,39 1058,1 1022,73 1094,1 1161,35 1185,4
34 398,49 536,2 702,67 728,45 855,33 1082,54 1006,58 1081,91 1166,76 1043,6
35 392,16 499,32 737,55 751,46 887,52 1093,28 1020,28 993,75 1120,66 1153,63
36 393,21 459,56 700,3 746,49 885,43 1202,37 1081,63 1054,92 1300,85 1102,99
37 388,16 526,01 693,85 701,93 876,27 1036,68 1137,19 1069,02 1156,17 1209,3
38 425,27 502,71 670,91 763,97 885,14 1338,21 1041,9 1105,31 1173,04 1106,3
39 458,81 485,29 769,42 768,16 924,16 1083,64 1033,95 1110,85 1163,9 1245,49
40 424,47 480,97 753,89 845,72 1104,75 1008,32 1155,92 1313,49 1151,92
41 418,06 538,48 661,58 817,68 1231,24 1021,45 1003,38 1256,29 1138,93
42 410,23 511,62 732,89 857,46 986,42 1021,8 1030,45 1185,67 1012,99
43 399,46 519,16 703,46 870,62 1104,95 1017,45 1007,2 1153,25 1042,97
44 416,36 517,92 715,85 949,51 1104,02 1064,95 1136,12 1176,67 1103,9
45 393,54 670,5 810,71 1024,25 981,03 1052,66 1004,75 1146,39
46 371,05 916,26 1082,93 1041,93 1060,14 1212,61 1194,72
47 403,49 844,07 1093,34 1077,68 988,58 1195,6 1142,53
48 401,63 807,31 1142,61 1015,86 1069,66 1144,68 1110,74
49 420,79 860,68 1064,56 1020,81 997,48 1066,53 1104,99
50 429,56 935,41 1014,36 1113,03 1018,67 1113,19 1019,37
51 946,71 1210,78 1036,34 1040,33 1170,76 1184,87
52 887,11 1085,58 1026,66 1024,5 1131,36 1161,19
53 825,31 1094,73 1203,78 1044,25 1133,93 1102,15
54 899,44 1139,28 1056,24 1017,53 1092,03 1077,75
55 909,77 1008,16 1100,35 1032,64 1136,05 1112,96
56 876,25 1072,03 1020,7 1046,97 1245,95 1092,63
57 919,32 1097,6 1024,31 989,95 1023,23 1129,3
58 873,62 1023,86 1068,59 1096,67 1213,52 1143,32
59 891,55 1053,41 1166,4 1088,78 1370,99 1115,34
60 821,11 1086,63 1055,5 1119,93 1160,64 1108,31
Average 286,945 340,38065 401,2584 509,64386 726,97538 742,27311 885,28717 1086,307 1070,3572 1061,9628 1163,1668 1147,5203
STDEV 14,820915 26,174336 22,83627 38,447041 56,347101 40,957569 40,497839 58,926459 61,594711 54,984906 80,878479 69,264238
Size (µm)
2,37406E-06 7,2377E-13 6,2366E-14 0,001807228
Day 1 Day 2 Day 3 Day 4
T test 2,17947E-06 0,558287719 0,842261384 0,072608939
2,28249E-10 4,71069E-17 8,56284E-08 2,70882E-06





Worm B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM
1 273,48 322,86 388,14 448,1 620,63 580,992 768,31 904,17 1101,39 986,43 1066,3 1191,1
2 347,13 340,98 362,58 416,94 676,66 787,95 844,99 1064,97 1070,54 1040,68 1042,85 990,94
3 359,35 540,59 402,78 535,23 632,25 735,02 754,13 982,67 1098,77 1011,31 1036,26 1127,06
4 302,23 360,21 333,13 505,54 617,81 749,09 799,67 1017,97 1089,62 1035,86 1044,45 1118,05
5 253,28 316,14 310,03 556,61 701,38 718,92 732,78 1012,62 1127,2 1035,56 1192,94 1329,26
6 353,43 350,63 388,3 633,35 628,18 801,64 771,31 1015,95 1076,51 986,24 1137,43 1132,46
7 352,57 322,73 348,2 523,53 584,17 686,13 780,51 1042,16 1161,62 1044,74 1182,26 1171,34
8 317,22 314,93 393,73 537,76 705,08 757,94 686,85 822,82 1196,28 1096,21 1074,75 1072,49
9 290,96 307,91 444,15 560,07 670,82 738,18 737,4 966,47 1062,64 1036,66 1201,95 1154,52
10 306,6 315,54 376,63 510,98 679,11 687,72 737,3 1039,63 1074,17 1034,29 1136,75 1111,63
11 280,95 309,43 312,42 494,26 820,16 686,81 733,57 925,23 982,88 1014,49 1150,2 1116,33
12 310,63 320,42 390,41 512,78 712 765,95 741,66 1007,09 912,43 1041,64 1007,78 1248,16
13 308,94 311,02 396,21 455,07 656,93 752,07 931,94 1005,12 1039,71 1056,12 1162,61 1193,5
14 329,35 318,53 343,43 534,36 650,85 738,24 774,18 959,23 1081,15 1022,96 1140,9 1208,47
15 372,92 310,88 323,22 558,41 662,84 710,26 959,21 1132,4 1109,35 1048,79 1093,09 1185,46
16 339,7 362,85 371,73 461,86 607,11 674,06 793,13 1038,74 998,12 1033,78 1117,91 1068,53
17 319,14 371,55 356,3 485,94 611,98 609,88 808,47 968,8 1105,15 996,4 1100,6 1191,08
18 308,47 330,42 388,08 528,02 681,1 755,83 766,76 1018,77 1191,47 1076,6 1028,33 1237,73
19 360,58 333,49 407 522,66 611,39 702,46 816,83 926,67 1021,08 1046,19 1036,48 1178,94
20 323,2 311,92 320,72 502,46 666,72 744,25 959,31 1018,68 1096,87 1027,07 1041,8 1071,97
21 364,27 337,61 387,72 480,44 637,71 665,06 750,99 921,64 1119,52 965,7 1098,76 1186,02
22 335,09 369,65 325,44 519,08 743,41 700,12 754,53 1011,18 1083,33 1055,56 1052,37 1050,77
23 306,19 335,18 324,09 424,36 668,06 675,18 705,76 951,34 997,76 1040,73 1118,16 1195,99
24 312,03 330,91 397,74 440,14 595,49 662,12 876,78 1072,34 1085,59 1190,62 1104,97 1023,82
25 322,11 308,06 358,58 475,39 645,25 563,77 692,08 954,69 1061,05 1020,39 1233,78 1087,62
26 301,34 361,43 387,52 444,1 605,49 840,1 754,3 917,49 1006,8 1021,18 1127,43 1162,02
27 296,45 324,04 454,58 446,93 679,65 587,7 674,25 929,1 1107,95 1092,94 1088,35 1158,2
28 292,2 310,76 448,77 472,47 608,09 572,13 928,76 932,86 1125,33 986,29 1070,82 1295,52
29 300,83 330,05 312,7 470,31 674,33 674,22 658,27 935,1 1075,39 983,94 1119,88 1092,3
30 331,23 306,68 404,46 520,41 612,15 590,82 828,31 981,13 1081,12 1033,31 1124,61 1094,25
31 304,19 325,32 448,28 458,13 672,56 750,81 834,54 954,75 1071,66 1083,55 1161,28 1261,24
32 301,32 358,86 396,88 469,49 713,02 725,72 866,53 937,74 1161,8 984,67 1108,59 1150,36
33 359,23 344,75 387,96 559,01 716,18 851,15 863,22 947,76 1142,2 962,78 1175,1 1170,96
34 318,26 330,86 310,64 475,96 670,48 692,62 714,34 945,3 1191,28 979,43 1170,99 1204,56
35 293,71 334,74 322,17 477,07 686,34 751,1 771,63 959,24 1075,23 1038,07 1099,59 1085,04
36 297,91 317,68 454,57 516,13 709,17 631,17 815,69 977,93 1236,77 1011,91 1091,98 1155,47
37 312,02 338,51 322,97 448,89 619,61 667,38 969,4 1025,49 1132,03 1034,66 1151,36 1034,85
38 332,4 349,12 384,77 490,36 610,33 702,3 899,5 1011,8 1154,35 1032,1 1176,89 1147,81
39 298,37 311,12 392,37 495,88 645,23 773,03 872,74 1003,55 1070,75 1103,82 1079,46 1103,34
40 289,54 328,96 310,01 484,07 638,97 719,24 785,45 996,21 1102,34 1052 1166,44 1192,7
41 367,46 361,6 319,72 552,34 645,26 691,56 756,29 943,22 1126,13 1071,39 1009,71 1284,66
42 368,07 327,3 415,61 538,74 676,49 804,68 738,38 1041,34 1187,15 978,59 1083,83 1397,26
43 320,41 335,13 349,47 482,43 672,15 810,7 808,25 1003,41 1148,99 1024,86 1227,69 1408,28
44 338,43 365,78 420,12 414,67 702,14 680,49 860,33 966,48 1156,35 1081,86 1174,99 1286,86
45 317,44 332,12 353,85 467,34 602,59 802,55 787,65 916,25 1021,51 1197,13 1114,67 1341,35
46 286,52 364,01 453,36 737,46 761,2 823,67 991,13 1170,14 982,09 1104,64 1187,95
47 316,7 353,63 410,02 586,64 722,03 1034,63 1056,07 1127,96 1262,17
48 328,59 322,5 447,39 603,31 693,89 1079,61 1041,18 1144,24 1351,8
49 329,98 410,83 673,45 686,93 1172,36 1012,61 1132,89 1229,43
50 351,88 387,77 705,37 798,62 1092,97 1006,02 1087,33 1247,01
51 330,01 398,24 709,31 746,9 1101,34 1034,94 1131,09 1237,27
52 336,29 354,64 581,06 638,03 1048,45 1024,32 1125,05 1332,65
53 312,26 411,32 710,07 587,83 1173,46 1057,86 1122,28 1265,52
54 348,36 395,33 655,83 698,54 1161,24 1007,22 1152,47 1321,8
55 355,07 324,92 686,32 750,97 1065,55 1103,5 1045,18 1348,76
56 397,6 595,04 805,24 1079,94 1024,91 1090,14 1382,57
57 366,51 749,98 802,32 1015,5 978,4 1149,93 1251,44
58 417,2 645,17 705,1 1027 1121,28 1093,03
59 367,17 646,91 741,17 1000,4 1176,55 1144,32
60 338,91 662,26 675,47 1097,24 1137,2 1298,59
Average 319,2175 337,33164 377,1565 495,73489 659,925 713,05587 797,60761 986,22 1093,986 1035,5898 1116,2595 1193,743
STDEV 27,234596 33,497864 42,328508 44,864032 47,561966 67,71545 77,152664 63,954628 61,891689 45,888454 51,804302 98,933556
Size (ђm)
0,157315742 4,53319E-08 1,89742E-10 0,000192867
T test
Day 1 Day 2 Day 3 Day 4
0,325490237 0,02193598 0,000774796 0,045154722
0,001207811 8,33692E-11 1,42968E-12 1,84437E-07
Size (ђm) Size (ђm) Size (ђm)
Figure S2. Developmental assay (raw data). The numbers indicate the size of 
each worm (in µm), measured as described in the ‘Methods’ section, as well as the 
average size of the worms from each condition per day. A standard two-tailed T-
test was used to analyse the data and determine the significant difference between 










# days Dead Censored Time (days) % Survival
1 0 0 1 100
2 0 0 2 100
4 0 3 4 100
8 1 1 8 98,969072
10 8 0 10 90,634835
12 16 0 12 73,966359
15 48 1 15 23,960933
17 20 0 17 2,178267
18 0 0 18 2,178267
20 2 0 20 0
% N2 NGM % N2 NGM
# days Dead Censored Time (days) % Survival
1 0 0 1 100
2 0 0 2 100
4 0 1 4 100
8 12 21 8 87,878788
10 15 2 10 67,906336
12 23 0 12 36,031933
15 18 0 15 11,086749
17 7 0 17 1,385844
18 1 0 18 0,000000
% N2 BІЇ+ % N2 B竸兩+
# days Dead Censored Time (days) % Survival
1 0 0 1 100
2 0 0 2 100
4 0 1 4 100
8 7 0 8 92,929293
10 30 0 10 62,626263
12 32 0 12 30,30303
15 30 0 15 0










# days Dead Censored Time (days) % Survival
1 0 0 1 100
3 0 0 3 100
4 0 3 4 100
5 0 25 5 100
6 0 4 6 100
7 1 0 7 98,507463
8 2 0 8 95,522388
10 11 2 10 79,104478
11 3 0 11 74,451273
12 2 1 12 71,349137
13 3 0 13 66,592528
16 6 0 16 57,079309
17 11 0 17 39,638409
19 25 0 19 0,000000
% N2 NGM % N2 NGM
# days Dead Censored Time (days) % Survival
1 0 0 1 100
3 0 5 3 100
4 0 2 4 100
5 0 4 5 100
6 0 4 6 100
7 0 0 7 100
8 6 21 8 93,617021
10 10 0 10 79,644332
11 6 1 11 71,260718
12 10 0 12 57,008574
13 13 0 13 38,480788
16 19 0 16 11,401715
17 5 0 17 4,275643
19 3 0 19 0
% N2 B竸兩+ % N2 B竸兩+
# days Dead Censored Time (days) % Survival
1 0 0 1 100
3 0 0 3 100
4 0 7 4 100
5 0 5 5 100
6 0 1 6 100
7 8 1 7 90,909091
8 7 7 8 82,853855
10 15 0 10 63,733735
11 6 0 11 56,085686
12 5 0 12 49,712313
13 10 0 13 36,965566
16 23 0 16 7,648048
17 6 0 17 0




   
  
 
# days Dead Censored Time (days) % Survival
1 0 0 1 100
2 0 0 2 100
3 0 0 3 100
4 0 0 4 100
5 0 0 5 100
6 0 0 6 100
7 0 0 7 100
9 1 2 9 98,823529
10 0 3 10 98,823529
11 7 0 11 90,067014
13 18 0 13 67,550261
14 24 0 14 37,527923
15 0 0 15 37,527923
16 12 0 16 22,516754
18 8 0 18 12,509308
19 7 0 19 3,752792
20 3 0 20 0
% N2 NGM % N2 NGM
# days Dead Censored Time (days) % Survival
1 0 0 1 100
2 0 0 2 100
3 0 0 3 100
4 0 0 4 100
5 0 0 5 100
6 0 0 6 100
7 3 3 7 97
9 16 5 9 80,489362
10 17 4 10 61,745264
11 18 0 11 40,371903
13 21 1 13 15,436316
14 11 0 14 1,28636
15 0 0 15 1,28636
16 1 0 16 0
% N2 B12+ % N2 B12+
# days Dead Censored Time (days) % Survival
1 0 0 1 100
2 0 0 2 100
3 0 0 3 100
4 0 0 4 100
5 0 0 5 100
6 0 2 6 100
7 16 0 7 83,673469
9 42 0 9 40,816327
10 16 0 10 24,489796
11 11 0 11 13,265306
13 9 0 13 4,081633
14 3 0 14 1,020408
15 0 0 15 1,020408
16 1 0 16 0
% N2 B12- % N2 B12-
Figure S3. Lifespan assay. The tables show the raw data from each trial (number 
of dead and censored worms per day, where each trial starts with 100 L4-stage 
worms), as well as the equivalent percent survival rate for each condition. The two 
tables underneath show the statistics for each trial, from which we used the P-value, 
calculated with a T-test, to determine the significant difference between the 










Worm 1 2 3 4 5 6 Total
1 22 80 72 14 5 2 195
2
3 19 79 42 28 5 1 174
4 20 85 47 30 5 1 188
5
6 16 73 45 28 19 5 186
7 17 84 43 0 1 0 145
8 19 79 38 4 4 1 145
9 15 82 58 15 4 0 174
10
Average 18,285714 80,285714 49,285714 17 6,1428571 1,4285714 172,42857
Standard deviation 2,4299716 3,9880775 11,799919 12,124356 5,843189 1,7182494 20,189578
N2 B竸兩-
Day
Worm 1 2 3 4 5 6 Total
1 114 137 39 9 0 299
2
3 46 97 31 5 16 6 201
4
5 62 156 44 3 0 4 269
6 69 145 58 23 2 2 299
7
8
9 39 131 56 35 14 4 279
10 39 113 50 24 18 6 250
Average 61,5 129,83333 46,333333 16,5 10 4,4 266,16667











Worm 1 2 3 4 5 6 Total
1 83 149 60 1 0 0 293
2 35 126 81 1 1 0 244
3 32 128 68 8 6 1 243
4 42 150 102 1 0 0 295
5 63 135 53 2 0 0 253
6 44 86 22 2 0 0 154
7 61 85 18 2 0 0 166
8
9
10 42 124 83 22 2 0 273
Average 50,25 122,875 60,875 4,875 1,125 0,125 240,125
Standard deviation 17,285419 25,062422 29,396003 7,2984832 2,1001701 0,3535534 53,43738
Day
N2 NGM
Worm 1 2 3 4 5 6 Total
1 18 78 43 11 0 0 150
2 14 68 36 2 0 0 120
3 12 83 67 15 7 0 184
4 18 66 52 9 1 0 146
5 36 97 15 1 0 0 149
6
7 26 49 14 9 3 0 101
8 39 56 15 3 0 0 113
9
10 20 36 45 23 12 0 136
Average 22,875 66,625 35,875 9,125 2,875 0 137,375
Standard deviation 9,9633256 19,580876 19,68638 7,4149945 4,421942 0 26,087422
N2 B竸兩-
Day
Worm 1 2 3 4 5 6 Total
1 34 121 62 0 0 0 217
2 39 135 61 18 0 0 253
3 31 133 40 0 1 0 205
4 40 112 46 12 1 0 211
5 64 120 3 0 0 0 187
6 52 123 24 2 5 0 206
7
8 59 108 10 13 7 2 199
9 42 116 12 0 0 0 170
10 51 150 25 2 0 0 228
Average 45,777778 124,22222 31,444444 5,2222222 1,5555556 0,2222222 208,44444









Worm 1 2 3 4 5 6 Total
1 43 114 93 29 11 0 290
2 37 119 150 28 8 1 343
3
4 50 142 126 9 0 0 327
5 44 117 99 0 0 0 260
6 43 121 115 0 0 0 279
7 36 102 72 35 2 0 247
8 35 122 118 20 0 0 295
9 51 108 130 1 0 0 290
10
Average 42,375 118,125 112,875 15,25 2,625 0,125 291,375
Standard deviation 6,0930288 11,80118 24,298369 14,498768 4,3732139 0,3535534 31,753234
Day
N2 NGM
Worm 1 2 3 4 5 6 Total
1 26 115 52 0 0 0 193
2 33 100 28 2 0 0 163
3 75 90 13 4 0 0 182
4 72 124 29 0 0 0 225
5 47 107 42 3 0 0 199
6 21 61 43 2 2 0 129
7 25 90 38 3 3 0 159
8 35 86 36 4 7 1 169
9 23 85 45 1 0 0 154
10 29 71 41 4 0 0 145
Average 38,6 92,9 36,7 2,3 1,2 0,1 171,8
Standard deviation 19,844955 19,232207 10,995454 1,5670212 2,2997584 0,3162278 28,361946
Day
N2 B竸兩-
Worm 1 2 3 4 5 6 Total
1 38 136 78 2 0 0 254
2 40 134 77 11 2 0 264
3 29 109 71 35 2 0 246
4 43 173 83 5 0 0 304
5 58 105 68 26 12 3 272
6 41 174 69 2 0 0 286
7 28 172 80 1 0 0 281
8 49 200 93 27 0 0 369
9 70 145 63 25 0 0 303
10
Average 44 149,77778 75,777778 14,888889 1,7777778 0,3333333 286,55556
Standard deviation 13,416408 32,155007 9,1210989 13,298914 3,929942 1 36,790322
Day
N2 B竸兩+
Figure S4. Brood size assay. The tables show the raw data for each trial of the 
brood size experiments. As described in the ‘Methods’ section, ten worms were 
used per condition per trial, and their progeny was counted for each day. The worm 
numbers highlighted in orange indicate worms that were censored due to unnatural 









Figure S5. HPLC-MS of BODIPY® TR-X ribose linked cobalamin (BoB12).   
A. Absorbance at 328 nm of sample from HPLC later used on HPLC-MS. B. 
Sample run on HPLC-MS. The UV absorbance curve has peaks at the expected 
wavelengths: ~361 nm for cyanocobalamin and 588 nm for BODIPY® TR-X. C. 











B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM
Number of worms assayed 51 53 62 36 26 41 51 37 67
Number of worms with neurite branching 1 0 0 8 3 3 34 15 18
Percent worms with branching 1,96 0,00 0,00 22,22 11,54 7,32 66,67 40,54 26,87
Day 1 Day 8 Day 15
B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM
Number of worms assayed 75 92 59 81 37 88
Number of worms with neurite branching 1 0 29 17 24 37
Percent worms with branching 1,33 0,00 49,15 20,99 64,86 42,05
Day 1 Day 8 Day 15
B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM B竸兩- B竸兩+ NGM
Number of worms assayed 41 35 35 43 44 48 33 34 18
Number of worms with neurite branching 0 0 0 17 6 8 30 16 9
Percent worms with branching 0,00 0,00 0,00 39,53 13,64 16,67 90,91 47,06 50,00
Day 1 Day 8 Day 15
Figure S6. pET-BAD plasmid containing the E. coli btuB and btuF genes. The 
TBAD promoter (blue) allows induction of the btuBF genes (orange and yellow) 
by L-arabinose. AmpR (green) encodes ampicillin resistance. (Nemoto-Smith, 2017) 
Figure S7. Neurite branching assay. The tables show the raw data for each trial, 
which indicate the percentage of worms with neurite branching per day for each 







Worm 1 2 3 4 5 6 7 Total
1 52 176 36 0 0 0 0 264
2 48 178 89 0 0 0 0 315
3 73 168 70 0 0 0 0 311
4 61 173 46 0 0 0 0 280
5 58 196 34 0 0 0 0 288
6 78 119 35 2 8 2 0 244
7 43 190 54 2 1 0 0 290
Average 59 171,42857 52 0,5714286 1,2857143 0,2857143 0 284,57143
Standard deviation 12,832251 25,085568 20,824665 0,9759001 2,9840848 0,7559289 0 25,01904
Worm 1 2 3 4 5 6 7 Total
1 37 106 34 0 0 0 0 177
2 30 114 56 0 0 2 0 202
3 45 113 58 8 3 0 0 227
4 41 103 26 3 0 0 0 173
5 32 97 53 2 0 0 0 184
6 36 112 68 6 3 0 0 225
7 49 104 49 2 3 1 0 208
Average 38,571429 107 49,142857 3 1,2857143 0,4285714 0 199,42857
Standard deviation 6,8521807 6,2716292 14,496305 3 1,6035675 0,7867958 0 22,112268
Worm 1 2 3 4 5 6 7 Total
1
2 33 101 18 5 1 0 0 158
3 62 173 29 0 0 0 0 264
4 83 124 7 2 0 0 0 216
5 65 122 15 0 0 0 0 202
6 73 120 9 0 0 0 0 202
7 37 129 38 3 0 0 0 207
Average 58,833333 128,16667 19,333333 1,6666667 0,1666667 0 0 208,16667
Standard deviation 19,883829 23,961775 12,011106 2,0655911 0,4082483 0 0 33,978915
Worm 1 2 3 4 5 6 7 Total
1 41 74 22 2 5 1 0 145
2 35 99 13 3 5 3 0 158
3 43 91 71 4 1 2 0 212
4 64 83 9 2 0 1 0 159
5 31 87 50 1 2 1 0 172
6 59 101 26 3 1 2 0 192
7 60 86 39 0 3 8 0 196
Average 47,571429 88,714286 32,857143 2,1428571 2,4285714 2,5714286 0 176,28571
Standard deviation 13,239551 9,3222724 22,041087 1,3451854 1,9880596 2,5071327 0 24,294816
Worm 1 2 3 4 5 6 7 Total
1 46 114 14 6 7 187
2 46 118 46 0 0 0 0 210
3 57 70 34 0 1 0 0 162
4 40 115 14 10 2 181
5 47 117 28 7 0 0 0 199
6 45 109 33 4 191
7 46 124 12 10 8 200
Average 46,714286 109,57143 25,857143 5,2857143 3 0 0 190











T test NGM vs B12- 2,2149E-05
T test NGM vs B12+ 0,001348685
T test NGM vs Pseudocobalamin 2,87861E-06
T test NGM vs BoB12 6,77261E-06
T test B12- vs B12+ 0,603558443
T test B12- vs Pseudocobalamin 0,087198654
T test B12- vs BoB12 0,376576324
T test B12+ vs Pseudocobalamin 0,087866342
T test B12+ vs BoB12 0,268384278





Worm 1 2 3 4 5 6 7 Total
1 34 210 38 0 0 1 0 283
2 38 200 25 1 1 2 0 267
3 53 222 51 11 1 0 0 338
4 29 156 65 9 1 2 1 263
5 42 136 42 16 0 0 0 236
6 37 226 14 2 3 4 0 286
7 35 144 44 1 1 0 0 225
8 41 212 6 10 269
9 39 109 25 11 2 5 0 191
10 36 189 9 1 235
Average 38,4 180,4 31,9 6,2 1,125 1,75 0,125 259,3
Standard deviation 6,328068 41,004607 19,31292 5,7888782 0,9910312 1,908627 0,3535534 40,290749
Worm 1 2 3 4 5 6 7 Total
1
2 8 50 32 28 7 2 0 127
3 13 63 47 34 10 4 1 172
4 35 52 61 29 177
5 31 84 44 5 164
6 27 34 46 50 23 5 1 186
7 25 36 45 40 35 7 0 188
8 10 33 42 22 16 10 2 135
9 24 47 46 14 4 4 0 139
10 23 61 46 20 150
Average 21,777778 51,111111 45,444444 26,888889 15,833333 5,3333333 0,6666667 159,77778
Standard deviation 9,4177728 16,541194 7,418071 13,596364 11,583034 2,8047579 0,8164966 22,813252
Worm 1 2 3 4 5 6 7 Total
1 19 40 17 12 3 3 0 94
2 14 42 29 17 14 4 0 120
3 18 53 31 15 5 4 0 126
4 15 67 61 55 60 3 0 261
5 11 57 53 35 26 9 1 192
6 10 45 40 37 27 24 4 187
7 8 54 37 14 17 12 142
8 10 40 36 21 22 29 2 160
9 12 37 34 18 9 9 0 119
10 26 44 37 15 2 2 0 126
Average 14,3 47,9 37,5 23,9 18,5 9,9 0,7777778 152,7
Standard deviation 5,4375239 9,5038004 12,240643 13,947919 17,225627 9,4098058 1,3944334 49,09639
Worm 1 2 3 4 5 6 7 Total
1 12 101 62 34 8 217
2 41 67 42 42 33 7 0 232
3 20 54 36 40 38 25 2 215
4 13 68 41 47 24 15 1 209
5 9 51 61 56 25 3 1 206
6 27 80 62 30 199
7
8 23 16 48 15 15 8 3 128
9 19 39 21 16 6 101
10 10 48 41 28 29 9 3 168
Average 19,333333 58,222222 46 34,222222 22,25 11,166667 1,6666667 186,11111
Standard deviation 10,185774 24,503968 13,838353 13,645309 11,585089 7,8081154 1,2110601 44,621868
Worm 1 2 3 4 5 6 7 8 Total
1 15 25 32 41 7 3 0 0 123
2 12 52 30 17 7 0 118
3 11 36 49 28 52 41 17 2 236
4
5 12 43 28 30 31 14 7 1 166
6 12 62 69 41 9 10 0 0 203
7 13 41 53 25 10 5 1 0 148
8 11 56 24 17 11 6 1 0 126
9 10 56 43 21 8 7 2 0 147
10 16 58 55 40 14 8 3 0 194
Average 12,444444 47,666667 42,555556 28,888889 16,555556 10,444444 3,875 0,375 86,117647











T test NGM vs B12- 8,38922E-06
T test NGM vs B12+ 5,42099E-05
T test NGM vs Pseudocobalamin 0,001752583
T test NGM vs BoB12 7,63283E-05
T test B12- vs B12+ 0,688910092
T test B12- vs Pseudocobalamin 0,14110907
T test B12- vs BoB12 0,872526936
T test B12+ vs Pseudocobalamin 0,13861813
T test B12+ vs BoB12 0,646927563





Worm 1 2 3 4 5 6 7 Total
1 41 176 103 10 5 0 0 335
2 47 192 52 11 9 4 0 315
3 43 141 19 1 0 0 0 204
4 61 197 48 0 0 0 0 306
5 35 169 65 2 3 0 0 274
6 29 176 47 3 2 0 0 257
7 28 183 46 2 0 0 0 259
8 61 173 51 9 2 0 2 298
9 26 181 78 3 0 0 0 288
10 27 178 65 0 0 0 0 270
Average 39,8 176,6 57,4 4,1 2,1 0,4 0,2 280,6
Standard deviation 13,314987 15,108497 22,336816 4,2282121 2,9608557 1,2649111 0,6324555 36,8064
Worm 1 2 3 4 5 6 7 Total
1 11 58 68 62 23 5 2 229
2 20 82 83 43 14 0 0 242
3 33 69 65 34 19 7 5 232
4 15 67 69 19 27 1 198
5 33 77 63 40 22 10 0 245
6 19 84 65 41 16 0 0 225
7
8 0 1 2 1 0 0 0 4
9 21 81 52 20 14 1 0 189
10
Average 19 74 66,428571 37 19,285714 3,4285714 1,4 195,5
Standard deviation 10,941402 27,294361 24,318937 18,677718 8,219098 3,8544964 1,9148542 79,873114
Worm 1 2 3 4 5 6 7 Total
1 30 65 64 49 8 2 1 219
2 32 63 88 44 12 6 2 247
3 23 69 67 43 15 4 1 222
4 10 77 132 57 9 7 1 293
5 23 60 88 37 7 8 5 228
6 38 70 82 55 21 8 5 279
7
8
9 32 68 93 56 9 8 2 268
10 8 106 66 45 8 5 3 241
Average 24,5 72,25 85 48,25 11,125 6 2,5 249,625
Standard deviation 10,77033 14,557767 22,123033 7,2259453 4,7640769 2,2038927 1,6903085 27,598848
Worm 1 2 3 4 5 6 7 Total
1 40 70 61 36 10 3 5 225
2 18 58 58 30 7 4 0 175
3 16 39 59 42 15 171
4 25 75 49 31 25 9 0 214
5 28 25 38 41 15 1 1 149
6 31 74 84 36 14 12 9 260
7 30 60 64 45 19 14 8 240
8 41 72 48 49 29 10 2 251
9 21 55 46 36 18 6 0 182
10 23 60 52 33 12 4 0 184
Average 27,3 58,8 55,9 37,9 16,4 7 2,7777778 205,1
Standard deviation 8,4859361 16,143798 12,644278 6,1904945 6,6699992 4,4440972 3,6324158 38,018855
Worm 1 2 3 4 5 6 7 Total
1 30 60 21 23 3 9 146
2 21 58 70 32 17 5 2 205
3 30 56 42 36 19 7 3 193
4 14 57 34 21 21 9 8 164
5 15 74 59 73 56 26 10 313
6 23 56 47 24 15 8 10 183
7 10 62 64 27 12 9 4 188
8 21 60 58 23 10 5 2 179
9 35 69 62 36 16 13 1 232
10 14 40 56 38 15 13 6 182
Average 21,3 59,2 51,3 33,3 18,4 10,4 5,1111111 198,5











T test NGM vs B12- 0,0204131
T test NGM vs B12+ 0,0583228
T test NGM vs Pseudocobalamin 0,0002705
T test NGM vs BoB12 0,000391
T test B12- vs B12+ 0,1048341
T test B12- vs Pseudocobalamin 0,761186
T test B12- vs BoB12 0,9265947
T test B12+ vs Pseudocobalamin 0,0110403
T test B12+ vs BoB12 0,010837
T test Pseudocobalamin vs BoB12 0,7315942
Figure S8. Cobalamin analogue brood size rescue assay. The tables show the 
raw data for each trial. The experiments were carried out as described in the 
‘Methods’ section, with ten worms used per condition per trial. The small tables 
show the P-values (from a two-tailed T-test) for each pair of conditions, with the 
ones in red indicating those which are significantly different to one another.  A. 
Trial 1. B. Trial 2. C. Trial 3. 
C. 
